👤 Heling Wang

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧪 BiometalDB 🧬 Extraction
4397
Articles
2763
Name variants
Also published as: Junli Wang, Xindi Wang, Junpeng Wang, Tingyu Wang, Guoqiang Wang, Yuxuan Wang, Hanzhi Wang, Zhi-Long Wang, Shanshan Wang, Wenfei Wang, Dengbin Wang, Yen-Sheng Wang, Chuanxin Wang, Zeyu Wang, Beibei Wang, Taicheng Wang, Xingguo Wang, Z P Wang, Yue-Min Wang, Chenghua Wang, Xianqiang Wang, Congrong Wang, Yanhai Wang, Du Wang, Xianzhe Wang, Zuoheng Wang, Yongyi Wang, Zhihui Wang, Yanhua Wang, Limeng Wang, H J Wang, Pei-Jian Wang, Yana Wang, Congrui Wang, Larry Wang, Yu-Zhuo Wang, Sihua Wang, Wanchun Wang, Jialin Wang, Xinying Wang, Shuguang Wang, Yinhuai Wang, Xiaobin Wang, Yuying Wang, Hebo Wang, Leli Wang, Jiayu Wang, Zhaojun Wang, Hai Wang, Si Wang, Re-Hua Wang, Xuping Wang, Bo Wang, Shubao Wang, Songjiao Wang, Hongjia Wang, Victoria Wang, Ling Wang, Jianjie Wang, Haining Wang, Dali Wang, Ji-Yang Wang, Cheng Wang, Weifan Wang, Yuanqiang Wang, Zhixiao Wang, Yaxian Wang, Zhigang Wang, Haochen Wang, Jia-Ying Wang, Shichao Wang, Ruosu Wang, N Wang, Haixing Wang, Guiqun Wang, Zhiting Wang, Dan Wang, Wangxia Wang, Jing-Long Wang, Yaqian Wang, Yafang Wang, Xing-Jun Wang, Dapeng Wang, Zhongyuan Wang, Junsheng Wang, Zhaohai Wang, He-Ping Wang, Minmin Wang, Wenzhou Wang, Zhaohui Wang, Yanfang Wang, Pengtao Wang, Leran Wang, Qianwen Wang, Hongkun Wang, Sa Wang, Y Alan Wang, Liyan Wang, Jou-Kou Wang, Mingda Wang, Chenfei Wang, Yuehan Wang, Simeng Wang, Yuhua Wang, Ruibin Wang, Haibo Wang, Ni Wang, Guoxiu Wang, Zhuangzhuang Wang, Yajie Wang, Zhixiang Wang, Sangui Wang, Xiantao Wang, Yan-Yang Wang, Mengjun Wang, Ruling Wang, Peihe Wang, Miao Wang, Zaihua Wang, Jun-Jie Wang, Mengyao Wang, Zhiyu Wang, Changzhen Wang, Xijun Wang, Chengjian Wang, Yiyi Wang, Mo Wang, Xiaolun Wang, Danan Wang, Fanchang Wang, Zilin Wang, Fanhua Wang, Supeng Perry Wang, Gavin Wang, Yi-Ying Wang, Yani Wang, Zhuowei Wang, Weiwei Wang, Haifeng Wang, Yi-Shiuan Wang, Yan-Chao Wang, Xiaotong Wang, Jia-Qi Wang, Yongliang Wang, Yongming Wang, Fengchong Wang, Jianyong Wang, Zeping Wang, Huaquan Wang, Xiaojia Wang, Tao Wang, Tianjun Wang, Siying Wang, Zhenze Wang, Zhijian Wang, Li Wang, Heming Wang, Jingtong Wang, Xuefei Wang, Yingqiao Wang, Xiao Qun Wang, Chun-Chieh Wang, Shuang-Xi Wang, Laiyuan Wang, Zhaoming Wang, Yinggui Wang, Qi-Jia Wang, Wen-Yan Wang, Mingming Wang, Peipei Wang, Chien-Hsun Wang, Qiuhong Wang, Monica Wang, Lexin Wang, Xiufen Wang, Yuehua Wang, Pingfeng Wang, Caiyan Wang, Weijie Wang, Yigang Wang, Jieyan Wang, Huiquan Wang, Chunsheng Wang, Yunhe Wang, Changtu Wang, Qingliang Wang, Guanghua Wang, Yongbin Wang, Zhaobo Wang, Minghui Wang, Junshi Wang, Jingyu Wang, Longsheng Wang, Fen Wang, Xianshu Wang, Jianwu Wang, Jun-Zhuo Wang, Zhixing Wang, Lei Wang, Yiyan Wang, Jinglin Wang, Jinhe Wang, Enhua Wang, Yuecong Wang, Xueying Wang, Jennifer T Wang, Xin-Hua Wang, Shijie Wang, Chun-Xia Wang, Yuanjiang Wang, Xiaojun Wang, Shunjun Wang, Chun-Juan Wang, M Wang, Jinfei Wang, Jinghuan Wang, Xuru Wang, Xiao-Lan Wang, Yu-Chen Wang, Zhi-Guo Wang, Luya Wang, Shuwei Wang, Pingchuan Wang, Qifan Wang, Xing-Quan Wang, Weiding Wang, Xuebin Wang, Yaling Wang, Chenyin Wang, Allen Wang, Liyuan Wang, Rong-Rong Wang, Wusan Wang, Wayseen Wang, Qianru Wang, Yi-Xin Wang, Hailin Wang, Yu-Hang Wang, Xuesong Wang, Haojie Wang, Wanxia Wang, Mengwen Wang, Hanping Wang, Yuhang Wang, Lueli Wang, Xinchang Wang, Oliver Wang, Shuge Wang, Jianhao Wang, Chong Wang, Kui Wang, Litao Wang, Zining Wang, Ming-Yang Wang, Hongxia Wang, Mingyi Wang, Hai Bo Wang, Bingnan Wang, Hongqian Wang, Jisheng Wang, Jiakun Wang, Maoju Wang, Xiaoqiu Wang, Dongyi Wang, Hai Yang Wang, Pengju Wang, Xiaofeng Wang, Huming Wang, Jian'an Wang, Qianrong Wang, Xiaowei Wang, Xiangkun Wang, Da Wang, Hongying Wang, Changying Wang, Changyu Wang, Xiaoqin Wang, Zhenxi Wang, Qiaoqiao Wang, Yu Tian Wang, Yupeng Wang, Xinli Wang, YueJiao Wang, Jian-chun Wang, Pengchao Wang, Xiao-Juan Wang, Siqing Wang, C Z Wang, Pengbo Wang, Baoli Wang, Yu-Zhe Wang, Gui-Qi Wang, Dazhi Wang, Yanwen Wang, Xingqin Wang, Shijin Wang, Wenming Wang, Fanxiong Wang, Tiansong Wang, Shuzhe Wang, Jie Wang, Jinling Wang, Yunfang Wang, Luyao Wang, Cun-Yu Wang, Zikang Wang, Quan-Ming Wang, Yingying Wang, Chia-Chuan Wang, Xintong Wang, Jufeng Wang, Xuejun Wang, Xiao-Qian Wang, Yijin Wang, Meng Yu Wang, Tianyi Wang, Chia-Lin Wang, Zhuo-Jue Wang, Yaohe Wang, Rong Wang, Hao-Hua Wang, Yong-Jun Wang, Xubo Wang, Dalong Wang, Yan-Ge Wang, Erika Y Wang, Ruixian Wang, Jin-Liang Wang, Shicung Wang, Saifei Wang, Jintao Wang, Zhenzhen Wang, Jiawei Wang, Beilei Wang, Huabo Wang, Huiyu Wang, Hongtao Wang, Chengjun Wang, Guo-Du Wang, Taoxia Wang, Zitao Wang, Jingwen Wang, Yibin Wang, Long Wang, Xinjing Wang, Qunzhi Wang, Liangliang Wang, Bangchen Wang, Yu-Fen Wang, Shibin Wang, Congcong Wang, Xiong Wang, Zhiren Wang, Xiaozhu Wang, Hong-Xia Wang, Qingyong Wang, Tianying Wang, Tammy C Wang, Huijie Wang, Tiansheng Wang, Mengzhao Wang, Jianshu Wang, Xinlong Wang, Benzhong Wang, Zhipeng Wang, Kaijie Wang, Xiaomin Wang, Peijun Wang, Zhiqiang Wang, Jundong Wang, Zheng Wang, Yueze Wang, Sujuan Wang, Qing-Yun Wang, Xiaoqing Wang, Zongqi Wang, Zhicun Wang, Fudi Wang, Seok Mui Wang, Wanbing Wang, Kejun Wang, Nanping Wang, Mingyang Wang, Wenxia Wang, Yaru Wang, Zikun Wang, Shidong Wang, Bei Bei Wang, Yu-Hui Wang, Rui Wang, Yige Wang, Tongxin Wang, Xiaohua Wang, Changjing Wang, Xingjin Wang, Bingjie Wang, Shaoyu Wang, Hui-Hui Wang, Zhenyu Wang, Baoying Wang, Yang-Yang Wang, Shi-Yao Wang, Lifei Wang, Fangfang Wang, Zhimei Wang, Kunpeng Wang, Binglong Wang, Daijun Wang, Qinghang Wang, Zi Wang, Shushu Wang, QingDong Wang, Qing K Wang, Fuhua Wang, Yanni Wang, Jianle Wang, Wenyan Wang, Jinning Wang, Ziqi Wang, Wei-Qi Wang, Yaolou Wang, Haoming Wang, Jian-Wei Wang, Tian Wang, Peixi Wang, Iris X Wang, Tongxia Wang, Mei-Xia Wang, Haiying Wang, Tielin Wang, Hongze Wang, Chung-Hsi Wang, Peiyao Wang, Linli Wang, Guanru Wang, Yuzhong Wang, Yunhan Wang, Jianan Wang, Menglong Wang, Yingxue Wang, Jiayi Wang, Dingxiang Wang, Ting Wang, Fenglin Wang, Jianqun Wang, Ran Wang, Kuan Hong Wang, Liusong Wang, Wen-Der Wang, Yixuan Wang, Feng Wang, Kaicen Wang, Eryao Wang, Yulei Wang, Huaibing Wang, Zhongzhi Wang, Jinrong Wang, Sujie Wang, Xiaozhong Wang, Xiao-Pei Wang, Li-Na Wang, H X Wang, Linjie Wang, Zhaosong Wang, Yafen Wang, Chuan-Wen Wang, Xiaoning Wang, Li-Xin Wang, Silas L Wang, Baocheng Wang, Hongyi Wang, Zhi-Xiao Wang, Shengjie Wang, Zhi-Hao Wang, Yaokun Wang, Shao-Kang Wang, Qunxian Wang, Jianghui Wang, Zhao Wang, Di Wang, Jianzhi Wang, Ruijing Wang, Ling Jie Wang, Qingshi Wang, Jianye Wang, Yuqiang Wang, Kangling Wang, Anxin Wang, Shengli Wang, Zhulin Wang, Hua-Wei Wang, Yiwen Wang, Yang Wang, Hanqi Wang, Changwei Wang, Honglei Wang, Yi Lei Wang, Wenkang Wang, Junjie Wang, Yazhou Wang, Peng-Cheng Wang, Chenzi Wang, Anqi Wang, Yuemiao Wang, Xuelin Wang, Rujie Wang, Dongyan Wang, Yuxue Wang, Wengong Wang, Qigui Wang, Junqing Wang, Ruhan Wang, Xinye Wang, Huihui Wang, Gengsheng Wang, Mark Wang, Zhidong Wang, Mengmeng Wang, Yuwen Wang, Liang Wang, Huaxiang Wang, Fangjun Wang, Huixia Wang, Haijiao Wang, Hong-Hui Wang, Yi-Shan Wang, Yunchao Wang, Junjun Wang, Binghai Wang, Xinguo Wang, Jun-Sing Wang, Lingzhi Wang, Yuexiang Wang, Hong-Gang Wang, Yen-Feng Wang, Xidi Wang, Jiawen Wang, Liangfu Wang, Lifeng Wang, Shihan Wang, Wentian Wang, Sa A Wang, Lee-Kai Wang, Yu-Wei Wang, Zumin Wang, Shau-Chun Wang, Jianjiao Wang, Tian-Tian Wang, Jiantao Wang, Edward Wang, Jianbo Wang, Qingfeng Wang, Wenran Wang, Xiaolin Wang, Fenghua Wang, Rongjia Wang, Shiqiang Wang, Caixia Wang, Guihu Wang, Xindong Wang, Wenxiu Wang, Xueguo Wang, YiLi Wang, Aizhong Wang, Qiqi Wang, Chengcheng Wang, D Wang, L Wang, Jianhua Wang, Qiuling Wang, Shaolian Wang, Wen-Qing Wang, Wenqing Wang, Yuchuan Wang, Guangdi Wang, Yiquan Wang, Huimei Wang, Genghao Wang, Zun Wang, Miranda C Wang, Annette Wang, Chi-Ping Wang, Hanmin Wang, Zhaoxi Wang, Shifeng Wang, Runze Wang, Mangju Wang, Junjiang Wang, Dong D Wang, Xiu-Ping Wang, Haijiu Wang, Linghuan Wang, Yiying Wang, Renqian Wang, Nana Wang, Xiangdong Wang, Shiyin Wang, Chaoyi Wang, Menghan Wang, Shuyue Wang, Yongmei Wang, Nanbu Wang, Lihua Wang, Hongyue Wang, Jianli Wang, Chunli Wang, Minghua Wang, Junkai Wang, Chenguang Wang, Siyue Wang, Jun Wang, Shu-Song Wang, Bingyan Wang, Qingping Wang, Zhong-Yu Wang, Fei-Fei Wang, Jennifer E Wang, Z-Y Wang, Dongxia Wang, Dang Wang, Zi-Hao Wang, Rihua Wang, Jutao Wang, Yanzhe Wang, Guohao Wang, Liming Wang, Yishu Wang, Xuemin Wang, Xianfeng Wang, Zixu Wang, Jingfan Wang, Guang-Jie Wang, Guixue Wang, Jiaojiao Wang, Yaxin Wang, Haibing Wang, Weizhong Wang, Hairong Wang, Hai-Jun Wang, Mingji Wang, Yongrui Wang, Huizhi Wang, Longfei Wang, Chongmin Wang, Jingyang Wang, Zhong-Ping Wang, Huanhuan Wang, Baisong Wang, Xiaohui Wang, Fengyang Wang, Wanliang Wang, Ziqiang Wang, Chuan Wang, Jeffrey Wang, Ying-Zi Wang, Ziwei Wang, Xian Wang, Hanyu Wang, Qiming Wang, Dedong Wang, Fengying Wang, Xiaoya Wang, Zhenhua Wang, Yanchun Wang, Keming Wang, Zi-Yi Wang, Dezhong Wang, Jingying Wang, Shouli Wang, Lan-lan Wang, Weiyu Wang, Yuhuai Wang, Jun Yi Wang, Wenying Wang, Xue-Feng Wang, Xing-Lei Wang, Yuehong Wang, Pengyu Wang, Yihe Wang, Guodong Wang, Weijian Wang, Wu-Wei Wang, Y Wang, Ruonan Wang, Jianbing Wang, Mian Wang, Dennis Qing Wang, Nannan Wang, Zuo Wang, Christine Wang, Ruixin Wang, Yaxiong Wang, Siwei Wang, Yuanzhen Wang, Wen-Chang Wang, Haijing Wang, X Wang, Melissa T Wang, Haixia Wang, Qianghu Wang, Hongsheng Wang, Xiurong Wang, Shaowei Wang, Shuo Wang, Zengtao Wang, Yun-Xing Wang, Songtao Wang, Mei Wang, Mengyun Wang, Qingming Wang, Ke-Feng Wang, Zhihao Wang, Haoqi Wang, X E Wang, Xin-Shang Wang, Dongmei Wang, Lingli Wang, Huai-Zhou Wang, Hua Wang, Kunzheng Wang, Mao-Xin Wang, Jingzhou Wang, Jiaqi Wang, Xingbang Wang, Wence Wang, Yongdi Wang, Xin-Qun Wang, Guoyi Wang, Jian-Guo Wang, Jiafu Wang, Pin Wang, Libo Wang, Junling Wang, J Z Wang, Haozhou Wang, Jing Wang, Hezhi Wang, T Q Wang, Xi-Hong Wang, Yuanfan Wang, Endi Wang, Hua-Qin Wang, Jeremy Wang, Songping Wang, Suyun Wang, Jiqing Wang, Shu-Ling Wang, Jennifer X Wang, Lily Wang, Yin-Hu Wang, Jen-Chywan Wang, Qingqing Wang, Shuangyuan Wang, Haihong Wang, Luyun Wang, Yake Wang, Ya-Nan Wang, Weicheng Wang, Jianxiang Wang, Zihua Wang, Lin Wang, Fu-Sheng Wang, Zongbao Wang, Tong-Hong Wang, Xianze Wang, Ting-Ting Wang, Haibin Wang, Xin-Yue Wang, Zhi-Gang Wang, Ziying Wang, Shukang Wang, Wen-Jun Wang, Delin Wang, Yating Wang, Xuehao Wang, Yefu Wang, Yi-Ning Wang, Cheng-zhang Wang, Jing J Wang, Xinglong Wang, Yanqing Wang, Tongyao Wang, Dongyang Wang, Deqi Wang, Qiao Wang, Alice Wang, Yunzhi Wang, Dayong Wang, Renxi Wang, Yeh-Han Wang, Mingya Wang, Longxiang Wang, Hualin Wang, Hailei Wang, Ao Wang, Wanyu Wang, Jiale Wang, Qiangcheng Wang, Huishan Wang, Yunqiong Wang, Xudong Wang, Xifu Wang, Wen-Xuan Wang, Dao Wen Wang, Zhi-Wei Wang, Xingchen Wang, Yanyang Wang, Yutao Wang, Huizhen Wang, Hu WANG, Y P Wang, Wen Wang, Qingsong Wang, Baofeng Wang, Ruo-Ran Wang, Yaobin Wang, Changliang Wang, Pintian Wang, Dai Wang, Su-Guo Wang, Ruting Wang, Fengzhen Wang, Qinrong Wang, HuiYue Wang, Baosen Wang, Shuhe Wang, Yifei Wang, Jiun-Ling Wang, Junhui Wang, Guangzhi Wang, Qijia Wang, Yushe Wang, Jinlong Wang, Zhouguang Wang, Huiyao Wang, Shuxin Wang, Yingyi Wang, Jing-Yi Wang, Yongxiang Wang, Zhi Wang, Dehao Wang, Yi-sheng Wang, Jiazhi Wang, Yunfei Wang, Mingjin Wang, Yaozhi Wang, Jinyu Wang, Jinmeng Wang, LiLi Wang, Shuai Wang, Yan Wang, Jun Kit Wang, Cui Wang, Zhan Wang, Dong-Jie Wang, Yangyang Wang, Xiangguo Wang, Runuo Wang, Ruimin Wang, Pengpu Wang, Nuan Wang, Guangyan Wang, Xin-Liang Wang, Minxiu Wang, Ruifang Wang, Hui Wang, Hongda Wang, Xiyan Wang, Jinxia Wang, Xinchen Wang, Haihua Wang, Delong Wang, Yayu Wang, Xue-Hua Wang, Xin-Peng Wang, Changqian Wang, Bei Wang, Ya-Han Wang, Chih-Liang Wang, P N Wang, Xiaoqian Wang, Xianshi Wang, Zhiruo Wang, Xueding Wang, Renxiao Wang, Yi-Ming Wang, Tianqi Wang, Ledan Wang, Rongyun Wang, Gan Wang, Qinqin Wang, Yuxiang Wang, Feimiao Wang, Mengyuan Wang, Chaofan Wang, Linshuang Wang, Yanhui Wang, Zhenglong Wang, Zongkui Wang, Zhenwei Wang, Xiyue Wang, Yi Fan Wang, Xiao-Ai Wang, Po-Jen Wang, Xinyang Wang, Linying Wang, Fa-Kai Wang, Yimeng Wang, Dong-Mei Wang, Anli Wang, Hui-Li Wang, Jianqing Wang, Honglun Wang, Wei-Feng Wang, Kaihao Wang, Jialing Wang, Shuren Wang, Cui-Fang Wang, Wenqi Wang, Peilin Wang, Wen-Fei Wang, Guang-Rui Wang, T Wang, Weiqing Wang, Ciyang Wang, Biao Wang, Kaihe Wang, Jieh-Neng Wang, Tony Wang, Yuehu Wang, Zhicheng Wang, Tongtong Wang, Zi Xuan Wang, Yingtai Wang, Xin-Xin Wang, Chu Wang, Tianhao Wang, Shukui Wang, Ching C Wang, Yulin Wang, Chunyang Wang, Yeqi Wang, Yinbo Wang, Kongyan Wang, Weiling Wang, Linxuan Wang, Shengya Wang, Yaqi Wang, Huating Wang, Aiting Wang, Ya Xing Wang, Daoping Wang, Shasha Wang, Wei-Lien Wang, Quanli Wang, Yanru Wang, L M Wang, Bijue Wang, H Wang, Jipeng Wang, Xiaoxia Wang, Shuu-Jiun Wang, Baitao Wang, Haimeng Wang, Chung-Hsing Wang, Weining Wang, M Y Wang, Wenwen Wang, Zhongsu Wang, Xiaochen Wang, Ligang Wang, Shaohsu Wang, Bing Qing Wang, Jiangbin Wang, Yajun Wang, Chunting Wang, Hemei Wang, En-hua Wang, H-Y Wang, Zixi Wang, Wenjing Wang, Haikun Wang, Ruxin Wang, Jianru Wang, Yongqiang Wang, Ouchen Wang, Jianyu Wang, Shen Wang, Yixi Wang, Zhi-Hong Wang, Li Dong Wang, Zhou-Ping Wang, Wen-Yong Wang, Meng-Lan Wang, Xiaojie Wang, Leying Wang, Yi-Zhen Wang, Y Y Wang, Jianlin Wang, Guoqing Wang, Jiani Wang, Guan-song Wang, You Wang, Xiangding Wang, Ke Wang, Wendong Wang, Yue Wang, Zhe Wang, K Wang, Zhuo Wang, Su'e Wang, Cangyu Wang, Erfei Wang, Xiaoming Wang, Aijun Wang, Xiaoye Wang, Jun-Sheng Wang, Wenxiang Wang, Yanjun Wang, Qiangqiang Wang, Yachun Wang, Haitao Wang, Tiancheng Wang, Gangyang Wang, Jianmin Wang, Jiabo Wang, Yijing Wang, Mengzhi Wang, Yinuo Wang, Zhou Wang, Guiying Wang, Xuezheng Wang, Shan Wang, Aoli Wang, Fuqiang Wang, Yawei Wang, Xianxing Wang, Ya-Long Wang, Yuyang Wang, Dong Hao Wang, Y-S Wang, Zelin Wang, Liqun Wang, Cunyi Wang, Qian-Zhu Wang, Yinan Wang, Panfeng Wang, Guangwen Wang, J Q Wang, Guang Wang, Yu-Ping Wang, John Wang, Jiaping Wang, Zhisheng Wang, Xuan-Ren Wang, Xiaowu Wang, Zhengyu Wang, Baowei Wang, Zhijun Wang, Zhong-Hao Wang, Fengzhong Wang, Jin-Da Wang, Zhaoqing Wang, Yuanbo Wang, Haixin Wang, Yaping Wang, Lixiu Wang, Mingxia Wang, Neng Wang, Guozheng Wang, Yan-Feng Wang, Huafei Wang, Yuhan Wang, Xingxing Wang, Wenhe Wang, Xing-Huan Wang, Xiansong Wang, Yishan Wang, Ruming Wang, Ya Qi Wang, Yueying Wang, Chunle Wang, Shihua Wang, W Wang, Hengjun Wang, Meihui Wang, Huanyu Wang, Ruinan Wang, Qiwei Wang, Zhong Wang, Shiyao Wang, Jian-Zhi Wang, Ruimeng Wang, Jinxiang Wang, Jinsong Wang, Bin-Xue Wang, Fuwen Wang, Yiou Wang, Shifa Wang, Yin Wang, Yanzhu Wang, Jia Bin Wang, Siyang Wang, Zhanggui Wang, Yueting Wang, Qingyu Wang, Qianqian Wang, Xiu-Lian Wang, Fengling Wang, Chenxi Wang, Cheng An Wang, Yipeng Wang, Weipeng Wang, Zechen Wang, Shuaiqin Wang, Xueqian Wang, Chan Wang, Guohang Wang, Cai-Yun Wang, Jiang Wang, Huei Wang, Yufeng Wang, Heng Wang, Qing-Liang Wang, Chuang Wang, Xiaofang Wang, Hao-Ching Wang, Junying Wang, Jianwei Wang, Jinhai Wang, Hanchao Wang, Penglai Wang, I-Ching Wang, S L Wang, Tianhu Wang, Sheng-Min Wang, Pan-Pan Wang, Duan Wang, Xuqiao Wang, Minghuan Wang, Wei-Wei Wang, Xiaojian Wang, Shuping Wang, Jinfu Wang, Biqi Wang, Zhenguo Wang, Fangyan Wang, Sainan Wang, Peijuan Wang, Pei-Yu Wang, Yuyan Wang, Fuxin Wang, Ji M Wang, Yange Wang, Yali Wang, Wenhui Wang, Leishen Wang, Lichan Wang, Xianna Wang, Wenbin Wang, Kenan Wang, Chih-Yuan Wang, Yanlei Wang, Ju Wang, Yanliang Wang, Keqing Wang, Bangshing Wang, Dayan Wang, Yongsheng Wang, Dinghui Wang, Zheyue Wang, Xinke Wang, Daqing Wang, Yan Ming Wang, He-Ling Wang, Shengyao Wang, Jiwen Wang, Xizhi Wang, Luxiang Wang, Dandan Wang, RongRong Wang, Heng-Cai Wang, Jindan Wang, Xiaoding Wang, Yumeng Wang, Xiao-Yun Wang, Meiding Wang, Zhilun Wang, Guo-hong Wang, Na Wang, Yanli Wang, Fubing Wang, Feixiang Wang, Zhiyuan Wang, Yi-Cheng Wang, Zhengwei Wang, Wenyuan Wang, Yu-Ying Wang, Jianqin Wang, Sijia Wang, Chuansen Wang, Huawei Wang, Kaiyan Wang, Qingyuan Wang, Yujia Wang, Lian Wang, Junrui Wang, Chao-Yung Wang, Zehao Wang, Ruixue Wang, Minjun Wang, Jin Wang, Xiaoxiao Wang, Jun-Feng Wang, Binquan Wang, Shuxia Wang, Donggen Wang, Deming Wang, Chenggang Wang, Chuduan Wang, Haichuan Wang, Catherine Ruiyi Wang, Hai-Feng Wang, Anthony Z Wang, Guanghui Wang, Jiahao Wang, Xiaosong Wang, Zijue Wang, Wenbo Wang, M-J Wang, Yu Wang, Yingping Wang, Zhengbing Wang, G Q Wang, Mengjing Wang, Zhendong Wang, Kailu Wang, Jinfeng Wang, Zhiguo Wang, Yusha Wang, Jianmei Wang, Kun Wang, Lihong Wang, Haoxin Wang, Haowei Wang, Ziqing Wang, Aihua Wang, Yuanyong Wang, Sanwang Wang, Doudou Wang, Hao-Yu Wang, Peirong Wang, Wenting Wang, Yibing Wang, He Wang, Jia-Peng Wang, Shixin Wang, En-bo Wang, Dong-Dong Wang, Hualing Wang, Hongyan Wang, Shaoying Wang, Yingjie Wang, Tianqing Wang, Guo-Hua Wang, Yongfei Wang, Lijing Wang, Hongli Wang, Zixian Wang, Niansong Wang, Liangxu Wang, Xinrong Wang, X-T Wang, Zhenning Wang, Dake Wang, Yu-Ting Wang, Zonggui Wang, Daping Wang, Joy Wang, Chenji Wang, Jingmin Wang, Yuyin Wang, Jin-Cheng Wang, Jiangbo Wang, Huiyang Wang, Chi Chiu Wang, He-Cheng Wang, Zhongjing Wang, Weina Wang, Qiaohong Wang, Qintao Wang, Jenny Y Wang, Zheyi Wang, Robert Yl Wang, Zhaotong Wang, Ya Wang, Fangyu Wang, Haobin Wang, Tianyuan Wang, Xinrui Wang, Zhehao Wang, Yihan Wang, Chuan-Jiang Wang, Jianjun Wang, Yongfeng Wang, Gaofu Wang, Ying-Piao Wang, Jingwei Wang, Mengjiao Wang, Chuyao Wang, Yanping Wang, Xinchun Wang, Shu Wang, Guibin Wang, Hong-Ying Wang, Linping Wang, Yugang Wang, Xinru Wang, Fengyun Wang, Heyong Wang, Ziping Wang, Yuegang Wang, Xiangyu Wang, Haoran Wang, Xiaomei Wang, Fang Wang, Lina Wang, Guowen Wang, Liyun Wang, Qingshui Wang, Baoyun Wang, Li-Juan Wang, Tongsong Wang, Jingyun Wang, Huiguo Wang, Zhibo Wang, Lou-Pin Wang, Renjun Wang, Huiting Wang, Junfeng Wang, Zihan Wang, Linhua Wang, Zhiji Wang, Fubao Wang, Eunice S Wang, Xiaojuan Wang, Yuewei Wang, Shuang Wang, Ruey-Yun Wang, Xiaoling Wang, Weihua Wang, Yanggan Wang, Jia Wang, Chaoqun Wang, Xiao-liang Wang, Manli Wang, Yongkang Wang, Huiwen Wang, Ting Chen Wang, Yixian Wang, Xinlin Wang, Shuya Wang, Bochu Wang, Kehao Wang, Sasa Wang, Mengshi Wang, Qiu-Ling Wang, Chengshuo Wang, Mengru Wang, Yiwei Wang, Xueyun Wang, Yijun Wang, Haomin Wang, Meng C Wang, Mengxiao Wang, Huan-You Wang, Jingheng Wang, Carol A Wang, Benjamin H Wang, Penglong Wang, Pei-Wen Wang, Jian-Long Wang, Wang Wang, Jinhui Wang, Yuanqing Wang, Jacob E Wang, Jian-Xiong Wang, Wenyu Wang, Chengze Wang, Hongmei Wang, Fengqiang Wang, Zijun Wang, Shaochun Wang, Qinwen Wang, Ruicheng Wang, Aixian Wang, Yanling Wang, Lu-Lu Wang, Linyuan Wang, Yeming Wang, Ye Wang, Tian-Yi Wang, Zhichao Wang, Dangfeng Wang, Jiucun Wang, Guo-Liang Wang, Guandi Wang, Zhuo-Xin Wang, Aili Wang, Fengliang Wang, Yingzi Wang, Lirong Wang, Xuekai Wang, Wei-En Wang, Jing-Xian Wang, Hesuiyuan Wang, Yuexin Wang, Suzhen Wang, Luping Wang, Xiuyu Wang, Zicheng Wang, Jiliang Wang, Rikang Wang, Xue Wang, Shudan Wang, Chun Wang, Hongxin Wang, Chenglong Wang, Junxiao Wang, Zhiqing Wang, Shawn Wang, Shunran Wang, Tiantian Wang, Youhua Wang, Xiao-Hui Wang, Qing-Yan Wang, Hanying Wang, Qiuping Wang, Yongzhong Wang, Jin-Xia Wang, Xiao-Tong Wang, Shun Wang, Xiaoqun Wang, Ching-Jen Wang, Xin Wang, Hanbin Wang, Yingwen Wang, Jia Bei Wang, Xiaodan Wang, Wenhan Wang, Jia-Yu Wang, Xiaozhi Wang, Xinkun Wang, Jinhao Wang, KeShan Wang, Shengdong Wang, Jinzhu Wang, Lihui Wang, Bicheng Wang, Chao-Jun Wang, Shaoyi Wang, Yajing Wang, Qing-Bin Wang, Feiyan Wang, Geng Wang, Chen Wang, Zhimin Wang, Cenxuan Wang, Wenjun Wang, Chuan-Chao Wang, Zexin Wang, Shu-Huei Wang, Yonggang Wang, Zhaoyu Wang, Xiaochuan Wang, Chuan-Hui Wang, Junshuang Wang, X F Wang, Li-Ting Wang, Chenxin Wang, Qiao-Ping Wang, Jingqi Wang, Xiongjun Wang, Shuang-Shuang Wang, Xu Wang, Houchun Wang, Yaodong Wang, Lujuan Wang, Jilin Wang, Peichang Wang, Keyun Wang, Ruixuan Wang, Zhangying Wang, Lianyong Wang, Dongyu Wang, Xinghui Wang, Binghan Wang, Guanduo Wang, Xian-e Wang, Guimin Wang, Xiaomeng Wang, Yuh-Hwa Wang, Jinru Wang, Mingyu Wang, Binbin Wang, Chaokui Wang, Linhui Wang, Youzhi Wang, Zhenqian Wang, Jialiang Wang, Sufang Wang, Haiyan Wang, Yankun Wang, Yingbo Wang, Zilong Wang, Xiao-Qun Wang, Lin-Fa Wang, Wenhao Wang, P Wang, Rui-Hong Wang, Xiao-jian WANG, Pei Chang Wang, Zhengkun Wang, Vivian Wang, Ying Wang, Zihuan Wang, Peiwen Wang, Chao Wang, Da-Zhi Wang, He-Tong Wang, Mofei Wang, Zezhou Wang, Liyong Wang, Bruce Wang, Hao-Tian Wang, Jin-Juan Wang, Yucheng Wang, Yong-Gang Wang, Saili Wang, Xiuwen Wang, Ruiquan Wang, Xinmei Wang, Zhezhi Wang, Xiao-Jie Wang, H Y Wang, Li-Dong Wang, Duanyang Wang, Kaiting Wang, Yikang Wang, Yichen Wang, Ting-Chen Wang, Meixia Wang, ZhenXue Wang, Juan Wang, Shouling Wang, Lan Wang, Li Chun Wang, Xingxin Wang, Ruibing Wang, Xue-Ying Wang, Bi-Dar Wang, Jiayang Wang, Suxia Wang, Yumin Wang, Qing Jun Wang, Xinbo Wang, Youli Wang, Yi-Ni Wang, Xinran Wang, Lixian Wang, Kan Wang, Ruiming Wang, Qing-Yuan Wang, Kai-Kun Wang, Yaoxian Wang, Qing-Jin Wang, Junmei Wang, Xin Wei Wang, J P Wang, Xufei Wang, Yuqin Wang, Handong Wang, Li-San Wang, Guoling Wang, Wenrui Wang, Zhongwei Wang, Shi-Han Wang, Ruoxi Wang, Huiping Wang, Mu Wang, Weihong Wang, Minzhou Wang, Yakun Wang, Da-Cheng Wang, Pengjie Wang, Qihua Wang, Ji-Nuo Wang, Deshou Wang, Xiaowen Wang, Yaochun Wang, Qihao Wang, Ruiying Wang, Tiange Wang, Xi Wang, Yindan Wang, Lixin Wang, Zhaofeng Wang, Guixin Wang, Erming Wang, Haoyu Wang, Kexin Wang, Yiqiao Wang, Qi-Qi Wang, Shuiyun Wang, Xi-Rui Wang, Cai-Hong Wang, Zhizheng Wang, Mingxun Wang, Liangli Wang, Theodore Wang, Alexander Wang, Huayang Wang, Yinyin Wang, Shuzhong Wang, Tingting Wang, Jiao Wang, Wenxian Wang, Jianghua Wang, Furong Wang, Shijun Wang, Le Wang, Guihua Wang, Xiaokun Wang, Xia Wang, Jiabei Wang, Guoying Wang, Zeyuan Wang, Jue Wang, Jin-E Wang, Jingru Wang, Chun-Li Wang, Xiaole Wang, Ermao Wang, Lanlan Wang, Ye-Ran Wang, Hao Wang, Xv Wang, Shikang Wang, Yufei Wang, Siyi Wang, Xiujuan Wang, Qinyun Wang, Xiangwei Wang, Jian-Hong Wang, David Q-H Wang, Chunjuan Wang, Weiyan Wang, Jia-Liang Wang, Yanxing Wang, Sheri Wang, Chenwei Wang, Haoping Wang, Sheng-Quan Wang, Xiangrong Wang, Xiao-Yi Wang, Huan Wang, Zhitao Wang, Xinyan Wang, J Wang, Kaixi Wang, Huihua Wang, Renwei Wang, Xiaoliang Wang, Xiao-Lin Wang, Tian-Lu Wang, Jiou Wang, Weiqin Wang, Jiamin Wang, Dennis Wang, Ji-Yao Wang, Pingping Wang, Jinyang Wang, Chen-Cen Wang, Chien-Wei Wang, Daolong Wang, Rong-Tsorng Wang, Yuwei Wang, Guo-Ping Wang, Zhentang Wang, F Wang, Xueju Wang, Saisai Wang, Zhehai Wang, Y B Wang, Xiao Wang, Guobing Wang, Kangmei Wang, Chunguo Wang, Longcai Wang, Haina Wang, Chih-Hsien Wang, Yuli Wang, Ling-Ling Wang, Zhangshun Wang, Xue-Lian Wang, Jianxin Wang, Da-Yan Wang, Xianghua Wang, Peng Wang, Yu Qin Wang, Zhao-Jun Wang, Rui-Rui Wang, Xingyue Wang, Man Wang, Daozhong Wang, Tian-Li Wang, Luhui Wang, Gaopin Wang, Mengze Wang, Jizheng Wang, Hong-Yan Wang, Dongying Wang, Wenkai Wang, Stephani Wang, Dan-Dan Wang, Yicheng Wang, Yusheng Wang, Junwen Wang, Gao Wang, Ruo-Nan Wang, Yifan Wang, Jueqiong Wang, Xuewei Wang, Jianning Wang, Yonglun Wang, Shiwen Wang, Lifang Wang, Fuyan Wang, Jian-Bin Wang, Chonglong Wang, Haiwei Wang, Yike Wang, Chunxia Wang, Kaijuan Wang, Minglei Wang, Jingxiao Wang, Luting Wang, David Wang, Ben Wang, Ji-zheng Wang, Yuncong Wang, Lei P Wang, Tingye Wang, Wenke Wang, Ping Wang, Min Wang, Qiang-Sheng Wang, Xuejing Wang, Zhanju Wang, Xixi Wang, Xiaodong Wang, Chaomeng Wang, Yanong Wang, Xinghao Wang, Jiaming Wang, Siyuan Wang, Jiu Wang, Ruizhi Wang, Qing Mei Wang, Wenyi Wang, Yiqing Wang, Cai Ren Wang, Lianchun Wang, Xing-Ping Wang, Xiaoman Wang, Yanjin Wang, Xueqin Wang, Chenliang Wang, Zhenshan Wang, Junhong Wang, Guiping Wang, Xianrong Wang, Xumeng Wang, Dajia Wang, Huang Wang, Huie Wang, Weiwen Wang, Ruiwen Wang, Qing Wang, Haohao Wang, Bao-Long Wang, P Jeremy Wang, Chengqiang Wang, Suli Wang, Lingyan Wang, Chi Wang, Meng Wang, Luwen Wang, Quan Wang, Yan-Jun Wang, Sen Wang, Ruining Wang, Xiaozhen Wang, Zhiping Wang, Xue-Yao Wang, Yuming Wang, Jingjing Wang, Jiazheng Wang, Yunong Wang, Chongze Wang, Rufang Wang, Qiuning Wang, Tiannan Wang, Liqing Wang, Wencheng Wang, Xuefeng Wang, Yongli Wang, Xinwen Wang, Runzhi Wang, Chaojie Wang, Wentao Wang, Zhifeng Wang, Yanan Wang, Mengqi Wang, Limin Wang, Donglin Wang, Shujin Wang, Chengbin Wang, Qiu-Xia Wang, Zhengxuan Wang, Yancun Wang, Yuhuan Wang, Wei Wang, G-W Wang, Bangmao Wang, Kejia Wang, Jinjin Wang, Qifei Wang, Guobin Wang, Chun-Lin Wang, Jing-Shi Wang, Jiheng Wang, Huajing Wang, Yanlin Wang, Chuansheng Wang, Cailian Wang, Beilan Wang, Luofu Wang, Yangpeng Wang, Jieqi Wang, Weilin Wang, Xiaoxuan Wang, Yangyufan Wang, Xiao-Fei Wang, Chen-Ma Wang, Yun Yong Wang, Shizhi Wang, B Wang, Yuling Wang, Yi-Yi Wang, Fanwen Wang, Aiyun Wang, Jian Wang, Chengyu Wang, Jing-Huan Wang, Ning Wang, Yichuan Wang, L F Wang, Chau-Jong Wang, Xin-Yang Wang, Yunzhe Wang, Xuewen Wang, Sheng-Ping Wang, Bi Wang, Qiuting Wang, Yan-Jiang Wang, Dongshi Wang, Yingna Wang, Jingyue Wang, Hongshan Wang, Chunjiong Wang, Hong-Yang Wang, Yingmei Wang, Danfeng Wang, Zhongyi Wang, Teng Wang, Chih-Hao Wang, Mingchao Wang, Yi-Chuan Wang, Chuning Wang, Shihao Wang, Ming-Wei Wang, Menglu Wang, Zhulun Wang, Wuji Wang, Dao-Xin Wang, Han Wang, Jincheng Wang, Thomas T Y Wang, Qingyun Wang, Guoliang Wang, Jihong Wang, Hong-Qin Wang, G Wang, Hsei-Wei Wang, Linfang Wang, Xiao Ling Wang, Ganyu Wang, Zhengdong Wang, Cuizhe Wang, Hongyu Wang, Tieqiao Wang, Lijuan Wang, Jingchun Wang, Youzhao Wang, Zijian Wang, Ziheng Wang, Xingyu Wang, Shuning Wang, Shaokun Wang, Zhifu Wang, Xinqi Wang, Jinqiu Wang, ZhongXia Wang, Yanyun Wang, Dadong Wang, Xingjie Wang, Yiting Wang, Zhongli Wang, Junyu Wang, Jianding Wang, Meng-Wei Wang, Yingge Wang, Zhenchang Wang, Qun Wang, Jin-Xing Wang, Lijun Wang, Shuqing Wang, Fu-Yan Wang, Sheng-Nan Wang, Feijie Wang, Qiuyan Wang, Ying-Wei Wang, Shitao Wang, Meng-hong Wang, Zhengyang Wang, Jinghong Wang, Zhiying Wang, Pei Wang, Weixue Wang, Shiyue Wang, Xiaohong Wang, Daiwei Wang, Jinghua Wang, S X Wang, Jian-Yong Wang, Zeying Wang, Can Wang, Kehan Wang, Yunzhang Wang, Jinping Wang, Chenchen Wang, Chun-Ting Wang, Yujiao Wang, Xinxin Wang, Ji Wang, Sui Wang, Wenqiang Wang, Yingwei Wang, Shuzhen Wang, Daixi Wang, Yanming Wang, Lin-Yu Wang, Hongyin Wang, Zhongqun Wang, Er-Jin Wang, Yi Wang, Ziyi Wang, Lianghai Wang, Zhendan Wang, Xiao-Ming Wang, Chengyan Wang, Hui Miao Wang, Jingyi Wang, Ranran Wang, Banghui Wang, Huilun Wang, Ai-Ting Wang, Wenxuan Wang, Yuan-Hung Wang, Zixuan Wang, Hailing Wang, Xuan-Ying Wang, Jiqiu Wang, Yalong Wang, Xiaogang Wang, Shu-qiang Wang, Yun-Jin Wang, Zijie Wang, Tianlin Wang, Mingqiang Wang, Lufang Wang, Jin'e Wang, Xiru Wang, Cuili Wang, GuoYou Wang, Zhizhong Wang, Haifei Wang, Guorong Wang, Xinyue Wang, Pei-Juan Wang, Jiangong Wang, Yingte Wang, Huajin Wang, Ruibo Wang, Kejian Wang, Cheng-Cheng Wang, Xusheng Wang, Shu-Na Wang, Panliang Wang, Mingxi Wang, Shenqi Wang, Zifeng Wang, Chaozhan Wang, Xiuyuan Hugh Wang, Yuping Wang, Xujing Wang, Kai Wang, Hongbing Wang, Sheng-Yang Wang, Jianfei Wang, Hang Wang, Jing-Jing Wang, Weizhi Wang, Jixuan Wang, De-He Wang, P L Wang, Ningjian Wang, Chunyi Wang, Isabel Z Wang, Yong Wang, Yiming Wang, Mingzhi Wang, Jiying Wang, Qian-Wen Wang, Shusen Wang, Xiaoting Wang, Baogui Wang, Mingsong Wang, Zixia Wang, Demin Wang, Shiyuan Wang, Qiuli Wang, C Wang, Dongliang Wang, Weixiao Wang, Yinsheng Wang, Chunmei Wang, Huaili Wang, Xuelian Wang, Yongjun Wang, Zhi-Qin Wang, Jiaying Wang, Yulong Wang, Ren Wang, Jingnan Wang, Qishan Wang, Zeneng Wang, Guangsuo Wang, Chijia Wang, Huiqun Wang, Hongcai Wang, Donghao Wang, Xing-Jin Wang, Zongji Wang, Shenao Wang, Jiaqian Wang, Xiaoying Wang, Yilin Wang, Hangzhou Wang, Wenchao Wang, Jieyu Wang, Li-E Wang, Xuezhen Wang, Liuyang Wang, Zhiqian Wang, Fang-Tao Wang, Qiong Wang, Meng-Meng Wang, Youji Wang, Jiafeng Wang, Xiaojing Wang, William Wang, Junmin Wang, Laijian Wang, Xuexiang Wang, Huiyan Wang, T Y Wang, Zhaofu Wang, Wen-mei Wang, Yalin Wang, Xinshuai Wang, Daqi Wang, Zhen Wang, Shi-Cheng Wang, Anni Wang, Chunhong Wang, Hai-Long Wang, Pan Wang, Charles C N Wang, Pengxiang Wang, Xianzong Wang, Xike Wang, Qianliang Wang, Chunyan Wang, Xuan Wang, Xiaofen Wang, Zhi-Jian Wang, Feng-Sheng Wang, Xiangru Wang, R Wang, Yi-Shu Wang, Jia-Lin Wang, Yonghong Wang, Lintao Wang, Pai Wang, Yanfei Wang, Xuanwen Wang, Lei-Lei Wang, Chenxuan Wang, James Wang, Xinhui Wang, Shengqi Wang, Yueshen Wang, Shan-Shan Wang, Dingting Wang, Zhige Wang, Jingfeng Wang, Yongqing Wang, Chenyang Wang, Ziliang Wang, Bao Wang, Xueyan Wang, Liping Wang, Xingde Wang, Weijun Wang, Sibo Wang, Yaoling Wang, Donghong Wang, Chenyu Wang, Justin Wang, Baolong Wang, Yiqi Wang, Fengyong Wang, Lichao Wang, Yachen Wang, Quanren Wang, Shiyu Wang, Boyu Wang, Aimin Wang, Zhenghui Wang, Hengjiao Wang, Xiaoxin X Wang, Weimin Wang, Mutian Wang, Zhuo-Hui Wang, Xingye Wang, Zou Wang, Yu-Wen Wang, Shaoli Wang, Xin-Ming Wang, Weirong Wang, Kangli Wang, Yaoxing Wang, Xuejie Wang, Qifeng Wang, Xiaoxin Wang, Yinghui Wang, Jianzhang Wang, Tom J Wang, Yaqiong Wang, Zongwei Wang, Yun-Hui Wang, Haiyun Wang, Zhiyou Wang, Lijin Wang, Jifei Wang, Haiyong Wang, Xiao-Xia Wang, Shyi-Gang P Wang, Chih-Yang Wang, Zhixin Wang, Jun-Jun Wang, Tianjing Wang, Zhixia Wang, Chuanhai Wang, Zhijie Wang, Silu Wang, Jianguo Wang, Ming-Hsi Wang, Liling Wang, Yanting Wang, Haolong Wang, Xue-Lei Wang, Ru Wang, Qinglin Wang, Christina Wang, Mimi Wang, Menghui Wang, Wenju Wang, Junhua Wang, S S Wang, Fangyong Wang, Lifen Wang, Zhenbin Wang, Yapeng Wang, Shaoshen Wang, B R Wang, Sugai Wang, Hequn Wang, Songlin Wang, Wenjie Wang, Xiang-Dong Wang, Ting-Hua Wang, Mingliang Wang, Chengniu Wang, Guoxiang Wang, E Wang, Xiaochun Wang, Xueting Wang, Ming-Jie Wang, Zhaojing Wang, Dongxu Wang, Yirui Wang, Jiatao Wang, Jing-Min Wang, Shih-Wei Wang, Zhengchun Wang, Chaoxian Wang, Zehua Wang, Qiyu Wang, Shuye Wang, Baojun Wang, Qing Kenneth Wang, Xichun Wang, Jianliu Wang, Junping Wang, Yudong Wang, Mingzhu Wang, Kangning Wang, Wei-Ting Wang, Hongfang Wang, Chengwen Wang, Changduo Wang, Jinkang Wang, Junya Wang, Fengge Wang, Jianping Wang, Chang Wang, Zhifang Wang, Deli Wang, Linghua Wang, Shitian Wang, Lingling Wang, Zhihua Wang, Jun-Ling Wang, Keyi Wang, Lingbing Wang, Peijia Wang, Ruizhe Wang, X O Wang, Wanyi Wang, Ganggang Wang, Pei-Hua Wang, Kaiyue Wang, Xiaojiao Wang, Xun Wang, Shiyang Wang, Ya-Ping Wang, Yirong Wang, Lixing Wang, Danyang Wang, Xiaotang Wang, Taian Wang, Ming Wang, Xiangcheng Wang, Xuemei Wang, Zhixiong Wang, Mengying Wang, Li-Yong Wang, Xinchao Wang, Jianlong Wang, Jinjie Wang, Nan Wang, Weidong Wang, Mei-Gui Wang, L-S Wang, Wuqing Wang, Z Wang, Ya-Zhou Wang, Xincheng Wang, Jing-Wen Wang, Jinyue Wang, Hongyun Wang, Huaizhi Wang, Yan-Zi Wang, Danling Wang, Dongqin Wang, Hongzhuang Wang, Chung-Teng Wang, Yan-Chun Wang, Shi-Xin Wang, Muxuan Wang, Yujie Wang, Yunbing Wang, Yahui Wang, Zhihong Wang, Xiaoshan Wang, Tienju Wang, Chiou-Miin Wang, Yuqian Wang, Shengyuan Wang, Yumei Wang, Ningyuan Wang, Minjie Wang, Zhenda Wang, Qing-Dong Wang, Horng-Dar Wang, Siqi Wang, Kaihong Wang, Hong-Kai Wang, Meiling Wang, Jiaxing Wang, Xueyi Wang, Zhuozhong Wang, Anlai Wang, Julie Wang, Jin-Bao Wang, Keke Wang, Zhang Wang, Yintao Wang, Yong-Bo Wang, Bing Wang, Dalu Wang, Minxian Wang, Zulong Wang, Gao T Wang, Gang Wang, Sophie H Wang, Xinquan Wang, Yi-Ting Wang, Honglian Wang, Ruyue Wang, Jia-Qiang Wang, Seungwon Wang, Shusheng Wang, Yanbin Wang, Chang-Yun Wang, Le-Xin Wang, Juling Wang, Haohui Wang, Chuanyue Wang, Tianqin Wang, Danqing Wang, Keyan Wang, Yeou-Lih Wang, Qinglu Wang, Sun Wang, Rui-Min Wang, Yong-Tang Wang, Xianwei Wang, Lixia Wang, Tong Wang, Xiaonan Wang, Feida Wang, Jiaxuan Wang, Mingrui Wang, Zixiang Wang, Y Z Wang, Yuliang Wang, Ming-Chih Wang, J J Wang, Huina Wang, Jingang Wang, Jinyun Wang, Min-sheng Wang, Wanyao Wang, Ziqiu Wang, Guo-Quan Wang, Xueping Wang, Qixue Wang, Hechuan Wang, Shang Wang, Chaohan Wang, M H Wang, L Z Wang, Jianhui Wang, Xifeng Wang, Xiaorong Wang, Yinong Wang, Zhixiu Wang, Jiaxi Wang, Jiahui Wang, Xiaofei Wang, Feifei Wang, Kesheng Wang, Rong-Chun Wang, Zhi-Xin Wang, Chaoyu Wang, Yongkuan Wang, Zuoyan Wang, Hsueh-Chun Wang, Xixiang Wang, Guanrou Wang, Songsong Wang, Hongyuan Wang, Yubing Wang, Xuliang Wang, Wen-Ying Wang, Xinglei Wang, Dao-Wen Wang, Yun Wang, Ze Wang, Jiyan Wang, Zai Wang, Guan Wang, Chih-Chun Wang, Yiqin Wang, X S Wang, Hongzhan Wang, Exing Wang, Shu-Jin Wang, Shangyu Wang, Shouzhi Wang, Yunduan Wang, Jiyong Wang, Dongdong Wang, Qingzhong Wang, Zi-Qi Wang, Renyuan Wang, Siyu Wang, Donghui Wang, Ming-Yuan Wang, Juxiang Wang, Muxiao Wang, Fu Wang, Fei Wang, Qiuyu Wang, Ertao Wang, Zhi Xiao Wang, Zunxian Wang, Hui-Nan Wang, Rongping Wang, Won-Jing Wang, Leiming Wang, Pu Wang, Shen-Nien Wang, Xiaona Wang, Meng-Ying Wang, Wen-Jie Wang, Jiaxin Wang, RuNan Wang, Jiemei Wang, Ningli Wang, Zhong-Hui Wang, Hong Wang, Hui-Yu Wang, Ziqian Wang, Xinzhou Wang, Zhoufeng Wang, Weiguang Wang, Zusen Wang, Jiajia Wang, Bin Wang, Shu-Xia Wang, Yu'e Wang, Laidi Wang, Xiao-Li Wang, Lu Wang, Zhugang Wang, Maojie Wang, Ganglin Wang, Xinyu Wang, Junlin Wang, Dong Wang, Yao Wang, Ya-Jie Wang, Zhiwu Wang, DongWei Wang, Hongdan Wang, Yanxia Wang, Maiqiu Wang, Guansong Wang, Qingtong Wang, Yingcheng Wang, Wenjuan Wang, Liying Wang, Xiaolong Wang, Weihao Wang, Qiushi Wang, Yingfei Wang, Haoyang Wang, Li-Li Wang, Yanbing Wang, Yingchun Wang, Guangming Wang, Kaiyuan Wang, Shiqi Wang, Qi-En Wang, Song Wang, Jing-Hao Wang, Lynn Yuning Wang, Zekun Wang, Rui-Ping Wang, Yining E Wang, Yuzhou Wang, Liu Wang, Maochun Wang, Cindy Wang, Qian-Liang Wang, Duo-Ping Wang, Linlin Wang, Taishu Wang, Xiang Wang, Qirui Wang, Baoming Wang, Liting Wang, Jiapan Wang, Lingda Wang, Xietong Wang, Jia-Mei Wang, Liwei Wang, Shaozheng Wang, Q Wang, Timothy C Wang, Mengyue Wang, Xing Wang, Yahong Wang, Yuyong Wang, Yujiong Wang, Guangliang Wang, Ya-Qin Wang, Yezhou Wang, Hongjian Wang, Su-Hua Wang, Qian-fei Wang, Meng-Dan Wang, Yuchen Wang, Hongpin Wang, Pengfei Wang, Ge Wang, Meijun Wang, Yan-Ming Wang, Haichao Wang, Tzung-Dau Wang, Runci Wang, Yan-Yi Wang, Cheng-Jie Wang, Chen-Yu Wang, Cong Wang, Yaxuan Wang, Y H Wang, Yongjie Wang, Yuntai Wang, Ranjing Wang, Yiru Wang, Anxiang Wang, Q Z Wang, Shimiao Wang, Guoping Wang, Junke Wang, Xingyun Wang, Zhengyi Wang, Shi-Qi Wang, Yanfeng Wang, Danxin Wang, Chaodong Wang, Zhiqi Wang, Chunyu Wang, Lijia Wang, Chunlong Wang, Haiping Wang, Qingfa Wang, Yu-Fan Wang, Baihan Wang, Chunxue Wang, Liewei Wang, Xinyi Wang, Fu-Zhen Wang, Qing-Mei Wang, Sheng Wang, Yi-Tao Wang, Dawei Wang, Xiaoyu Wang, Ziling Wang, Zhonglin Wang, Rurong Wang, Qingchun Wang, Qiang Wang, Suiyan Wang, Xu-Hong Wang, Jie Jin Wang, Chenyao Wang, Fei-Yan Wang, Shi Wang, Zhiyong Wang, Jieda Wang, Xiaoqi Wang, Linshu Wang, Ruxuan Wang, Qian Wang, Qianxu Wang, Fangjie Wang, Zhaoxia Wang, Jeremy R Wang, Mingmei Wang, Jingkang Wang, Jen-Chun Wang, Changyuan Wang, Chenglin Wang, Meng-Ru Wang, Tianpeng Wang, Zhongfang Wang, Xuedong Wang, Zhuoying Wang, Bingyu Wang, Xuelai Wang, Weilong Wang, Mengge Wang, Qin Wang, Da-Li Wang, Xuanyi Wang, Hongjuan Wang, Zhi-Hua Wang, Hong-Wei Wang, Yulai Wang, Gongming Wang, Yongni Wang, Mengya Wang, Yadong Wang, Chenghao Wang, Hongbo Wang, Kaiming Wang, Haonan Wang, Guanyun Wang, Yilu Wang, Quanxi Wang, Weiyuan Wang, Xiujun Wang, Liang-Yan Wang, Jianshe Wang, Yingxiong Wang, Cunchuan Wang, Jing-Zhai Wang, Yuelong Wang, Yuqi Wang, Xiaorui Wang, Qianjin Wang, Huijun Wang, Xiaobo Wang, Guoqian Wang, Luhong Wang, Kaining Wang, Chaohui Wang, Yanhong Wang, J-Y Wang, Qi-Bing Wang, Xiaohu Wang, Jiayan Wang, Cui-Shan Wang, Lulu Wang, Yong-Jie Wang, Shixuan Wang, Yuanyuan Wang, Jianying Wang, Haizhen Wang, Shuiliang Wang, Qianbao Wang, Jung-Pan Wang, Rixiang Wang, A Wang, Hanbing Wang, Caiqin Wang, Peigeng Wang, Yuan Wang, Yuzhuo Wang, Yubo Wang, Xianding Wang, Qiaoqi Wang, Cuiling Wang, Ai-Ling Wang, Hailong Wang, Yihao Wang, Lan-Wan Wang, Haihe Wang, S Wang, Sha Wang, Xiaoli Wang, David Q H Wang, Jianfang Wang, Yuting Wang, Jinhuan Wang, Kaixu Wang, Hongwei Wang, Yi-Wen Wang, Yizhe Wang, Shengyu Wang, Yanmei Wang, Huimin Wang, Youjie Wang, Kunhua Wang, Chongjian Wang, Ziyun Wang, Tianhui Wang, Huiying Wang, Yue-Nan Wang, Peiyin Wang, Hongbin Wang, Hong Yi Wang, Xinjun Wang, Yian Wang, Liyi Wang, Yunce Wang, Yi-Xuan Wang, Yitao Wang, Jiali Wang, Junqin Wang, Yuebing Wang, Yiping Wang, Yunpeng Wang, Yuxing Wang, Shuqi Wang, Ziyu Wang, Hongjie Wang, Xiaoyan Wang, Lianshui Wang, Xiaolu Wang, Wenya Wang, Fan Wang, Jinhua Wang, Sidan Wang, Lixiang Wang, Y L Wang, Xue-Rui Wang, Kai-Wen Wang, Zhongyu Wang, Xiaoyang Wang, Hongyang Wang, Rencheng Wang, Yinxiong Wang, Yuanli Wang, Zhuqing Wang, Y-H Wang, Yuhui Wang, Xitian Wang, Weizhen Wang, Qi Wang, Qiyuan Wang, Changlong Wang, Yatao Wang, Tengfei Wang, Yehan Wang
articles
Yanzhe Wang, Xiaoyu Yin, Lei Li +2 more · 2016 · PloS one · PLOS · added 2026-04-24
The apolipoprotein C3 (APOC3) gene, which is a member of the APOA1/C3/A4/A5 gene cluster, plays a crucial role in lipid metabolism. Dyslipidemia is an important risk factor for ischemic stroke. In the Show more
The apolipoprotein C3 (APOC3) gene, which is a member of the APOA1/C3/A4/A5 gene cluster, plays a crucial role in lipid metabolism. Dyslipidemia is an important risk factor for ischemic stroke. In the present study, we performed a hospital-based case-control study of 895 ischemic stroke patients and 883 control subjects to examine the effects of four APOC3 single nucleotide polymorphisms (SNPs) (rs2854116, rs2854117, rs4520 and rs5128) on the risk of ischemic stroke in a northern Chinese Han population. The SNaPshot Multiplex sequencing assay was used for SNP genotyping, and the potential association of genotype distributions and allele frequencies with ischemic stroke was analyzed statistically. Compared with the GG genotype, the CC+GC genotype of rs5128 was significantly associated with an increased risk in females (adjusted OR = 3.38, 95% CI = 1.82-6.28, P <0.01) after all of the risk factors were adjusted for with logistic regression analyses. A similar relationship was found between the rs4520 polymorphism and ischemic stroke risk in Han Chinese women. Under a recessive genetic model, the TT+TC genotypes of this variant increased ischemic stroke risk (adjusted OR = 2.05; 95% CI = 1.28-3.29; P <0.01). Haplotype analysis revealed that in males, the T-C-T-C haplotype of rs2854116-rs2854117-rs4520-rs5128 was significantly more frequent in the ischemic stroke group than in the control group (OR = 1.49, 95% CI = 1.18-1.87, P<0.01). The results of our study indicate that the APOC3 polymorphisms contribute to ischemic stroke susceptibility in females in the northern Chinese Han population. Show less
📄 PDF DOI: 10.1371/journal.pone.0163910
APOC3
Kailian Xu, Shiyu Guo, Tianjing Zhao +14 more · 2016 · BioMed research international · added 2026-04-24
Hepatitis E virus- (HEV-) mediated hepatitis has become a global public health problem. An important regulatory protein of HEV, ORF3, influences multiple signal pathways in host cells. In this study, Show more
Hepatitis E virus- (HEV-) mediated hepatitis has become a global public health problem. An important regulatory protein of HEV, ORF3, influences multiple signal pathways in host cells. In this study, to investigate the function of ORF3 from the swine form of HEV (SHEV), high-throughput RNA-Seq-based screening was performed to identify the differentially expressed genes in ORF3-expressing HepG2 cells. The results were validated with quantitative real-time PCR and gene ontology was employed to assign differentially expressed genes to functional categories. The results indicated that, in the established ORF3-expressing HepG2 cells, the mRNA levels of CLDN6, YLPM1, APOC3, NLRP1, SCARA3, FGA, FGG, FGB, and FREM1 were upregulated, whereas the mRNA levels of SLC2A3, DKK1, BPIFB2, and PTGR1 were downregulated. The deregulated expression of CLDN6 and FREM1 might contribute to changes in integral membrane protein and basement membrane protein expression, expression changes for NLRP1 might affect the apoptosis of HepG2 cells, and the altered expression of APOC3, SCARA3, and DKK1 may affect lipid metabolism in HepG2 cells. In conclusion, ORF3 plays a functional role in virus-cell interactions by affecting the expression of integral membrane protein and basement membrane proteins and by altering the process of apoptosis and lipid metabolism in host cells. These findings provide important insight into the pathogenic mechanism of HEV. Show less
📄 PDF DOI: 10.1155/2016/1648030
APOC3
Sen-Lin Hu, Guang-Lin Cui, Jin Huang +2 more · 2016 · Scientific reports · Nature · added 2026-04-24
Apolipoprotein C-III (APOC3) is a key regulator of plasma triglycerides levels. Increasing evidence has shown that loss-of-function mutations in APOC3 is associated with reduction in plasma triglyceri Show more
Apolipoprotein C-III (APOC3) is a key regulator of plasma triglycerides levels. Increasing evidence has shown that loss-of-function mutations in APOC3 is associated with reduction in plasma triglycerides levels and will confer a benefit in patients at high risk for cardiovascular disease. However, these favorable mutations were extremely distribution discrepant among different ethnics. In this study, the APOC3 gene was resequenced and we identified a common variant which located in the microRNA-binding site in APOC3 and would affect its expression and the risk of coronary heart disease (CHD). The molecular mechanism was explored. We found that the T allele of rs4225 suppressed APOC3 translation by facilitating miR-4271 binding, but not the G allele. Subjects carrying the GG genotype had higher plasma APOC3 levels (p for trend = 0.03) than those with the TT genotype. Furthermore, the T allele was significantly associated with decreased triglyceride levels [Beta (SE): -0.024 (0.020), P = 0.03]. Finally, the case-control study suggested that the TT genotype resulted in a significant reduction in overall CHD risk [OR, 0.89 (95% confidence interval, 0.77-0.98), P = 0.009]. In conclusion, our results provide evidence that the rs4225 in the 3'-UTR of APOC3 might contribute to the risk of CHD by interfering with miR-4271 binding. Show less
📄 PDF DOI: 10.1038/srep32700
APOC3
Yun Tao, Yisong Xiong, Huimin Wang +6 more · 2016 · Lipids in health and disease · BioMed Central · added 2026-04-24
The fatality rate for cardiovascular disease (CVD) has increased in recent years and higher levels of triglyceride have been shown to be an independent risk factor for atherosclerotic CVD. Dysfunction Show more
The fatality rate for cardiovascular disease (CVD) has increased in recent years and higher levels of triglyceride have been shown to be an independent risk factor for atherosclerotic CVD. Dysfunction of endothelial cells (ECs) is also a key factor of CVD. APOC3 is an important molecule in lipid metabolism that is closely associated with hyperlipidemia and an increased risk of developing CVD. But the direct effects of APOC3 on ECs were still unknown. This study was aimed at determining the effects of APOC3 on inflammation, chemotaxis and exudation in ECs. ELISA, qRT-PCR, immunofluorescence, flow cytometry and transwell assays were used to investigate the effects of APOC3 on human umbilical vein endothelial cells (HUVECs). SiRNA-induced TNF-α and JAM-1 silencing were used to observe how APOC3 influenced the inflammatory process in the ECs. Our results showed that APOC3 was closely associated with the inflammatory process in ECs, and that this process was characterized by the increased expression of TNF-α. Inflammatory processes further disrupted the tight junctions (TJs) between HUVECs by causing increased expression of JAM-1. JAM-1 was involved in maintaining the integrity of TJs, and it promoted the assembly of platelets and the exudation of leukocytes. Changes in its expression promoted chemotaxis and the exudation of ECs, which contributed to atherosclerosis. While the integrity of the TJs was disrupted, the adhesion of THP-1 cells to HUVECs was also increased by APOC3. In this study, we describe the mechanism by which APOC3 causes inflammation, chemotaxis and the exudation of ECs, and we suggest that controlling the inflammatory reactions that are caused by APOC3 may be a new method to treat CVD. Show less
📄 PDF DOI: 10.1186/s12944-016-0326-0
APOC3
Wenhui Wang, Lei Xu, Pengyu Liu +7 more · 2016 · Neoplasia (New York, N.Y.) · Elsevier · added 2026-04-24
Aberrant activation of Wnt/β-catenin signaling plays a key role in the onset and development of hepatocellular carcinomas (HCC), with about half of them acquiring mutations in either CTNNB1 or AXIN1. Show more
Aberrant activation of Wnt/β-catenin signaling plays a key role in the onset and development of hepatocellular carcinomas (HCC), with about half of them acquiring mutations in either CTNNB1 or AXIN1. However, it remains unclear whether these mutations impose sufficient β-catenin signaling or require upstream Wnt ligand activation for sustaining optimal growth, as previously suggested for colorectal cancers. Using a panel of nine HCC cell lines, we show that siRNA-mediated knockdown of β-catenin impairs growth of all these lines. Blocking Wnt secretion, by either treatment with the IWP12 porcupine inhibitor or knockdown of WLS, reduces growth of most of the lines. Unexpectedly, interfering with Wnt secretion does not clearly affect the level of β-catenin signaling in the majority of lines, suggesting that other mechanisms underlie the growth-suppressive effect. However, IWP12 treatment did not induce autophagy or endoplasmic reticulum (ER) stress, which may have resulted from the accumulation of Wnt ligands within the ER. Similar results were observed for colorectal cancer cell lines used for comparison in various assays. These results suggest that most colorectal and liver cancers with mutations in components of the β-catenin degradation complex do not strongly rely on extracellular Wnt ligand exposure to support optimal growth. In addition, our results also suggest that blocking Wnt secretion may aid in tumor suppression through alternative routes currently unappreciated. Show less
📄 PDF DOI: 10.1016/j.neo.2016.10.004
AXIN1
Weijie Wu, Qingqing Liu, Yuxi Liu +2 more · 2016 · Biochemical and biophysical research communications · Elsevier · added 2026-04-24
Dixdc1 (DIX domain containing-1), the mammalian homolog of Ccd1 (Coiled-coil-Dishevelled-Axin1), is a protein containing a coiled-coil domain and a Dishevelled-Axin (DIX) domain. As a novel component Show more
Dixdc1 (DIX domain containing-1), the mammalian homolog of Ccd1 (Coiled-coil-Dishevelled-Axin1), is a protein containing a coiled-coil domain and a Dishevelled-Axin (DIX) domain. As a novel component of the Wnt pathway, Dixdc1 has been reported to be able to promote neural progenitor proliferation and neuronal differentiation via Wnt/β-catenin signaling. But there still remains something unknown about Dixdc1 distribution and functions in the lesion and regeneration of the peripheral nervous system (PNS), so we tried to investigate dynamic changes of Dixdc1 expression in a rat sciatic nerve crush (SNC) model in this study. First of all, we detected SNC-induced increased levels of Dixdc1 in Schwann cells and interestingly identified parallel expression of PCNA (proliferation cell nuclear antigen) with Dixdc1. Besides, we observed up-regulated Dixdc1 during the process of TNF-α-induced Schwann cell proliferation. Also, we discovered that Dixdc1 could promote G1-S phase transition accompanied with the up-regulation of CyclinD1 and down-regulation of p21. More importantly, enhanced effects of Dixdc1 on cell proliferation were confirmed to be associated with PI3K activation. Not only blocking of the PI3K but Dixdc1 knockdown led to significantly decreased ability for proliferation, as well as down-regulation of CyclinD1 and up-regulation of p21. In summary, these data demonstrated that Dixdc1 might participate in Schwann cell proliferation by targeting CyclinD1 and p21 at least partially through the PI3K/AKT activation. Show less
no PDF DOI: 10.1016/j.bbrc.2016.08.058
AXIN1
Xiao Fu, Hui Li, Chunxiao Liu +3 more · 2016 · OncoTargets and therapy · added 2026-04-24
Recent studies indicate that long noncoding RNAs (lncRNAs) play a key role in the control of cellular processes such as proliferation, metastasis, and differentiation. The lncRNA dysregulation has bee Show more
Recent studies indicate that long noncoding RNAs (lncRNAs) play a key role in the control of cellular processes such as proliferation, metastasis, and differentiation. The lncRNA dysregulation has been identified in all types of cancer. We previously found that lncRNA AK126698 suppresses cisplatin resistance in A549 cells through the Wnt/β-catenin signaling pathway. However, the clinical significance of lncRNA AK126698 and the molecular mechanisms through which it regulates cancer cell proliferation and migration are largely unknown. We examined the expression of lncRNA AK126698 in 56 non-small cell lung cancer (NSCLC) tissue samples and three NSCLC cell lines using quantitative real-time polymerase chain reaction. Gain and loss of function approaches were used to evaluate the biological function of AK126698 in NSCLC cells. The effects of lncRNA AK126698 on cell proliferation were investigated using cell counting kit-8 and 5-ethynyl-2'-deoxyuridine assays, and apoptosis was measured by flow cytometry. Protein levels of AK126698 targets were evaluated by Western blotting. Our results showed that lncRNA AK126698 was significantly downregulated in NSCLC tissues, compared with paired adjacent nontumor tissue samples. Furthermore, lower AK126698 expression was associated with larger tumor size and advanced tumor stage. Ectopic AK126698 expression inhibited cell proliferation and migration and induced apoptosis. Conversely, decreased AK126698 expression promoted cell proliferation and migration and inhibited cell apoptosis. Importantly, we demonstrated that Frizzled-8, a receptor of Wnt/β-catenin pathway, was a target of AK126698. Furthermore, AK126698 could inhibit the activation of Wnt/β-catenin pathway, which was demonstrated by measuring the expression levels of Axin1, β-catenin, c-myc, cyclin D1, and E-cadherin. It was found in the study that lncRNA AK126698 inhibits the proliferation and migration of NSCLC cells by targeting Frizzled-8 to suppress the Wnt/β-catenin signaling pathway. It may provide a new target for therapeutic intervention in NSCLC. Show less
📄 PDF DOI: 10.2147/OTT.S100633
AXIN1
Xiao-Qin He, Yue-Qiang Song, Rui Liu +10 more · 2016 · PloS one · PLOS · added 2026-04-24
Axin-1, a negative regulator of Wnt signaling, is a versatile scaffold protein involved in centrosome separation and spindle assembly in mitosis, but its function in mammalian oogenesis remains unknow Show more
Axin-1, a negative regulator of Wnt signaling, is a versatile scaffold protein involved in centrosome separation and spindle assembly in mitosis, but its function in mammalian oogenesis remains unknown. Here we examined the localization and function of Axin-1 during meiotic maturation in mouse oocytes. Immunofluorescence analysis showed that Axin-1 was localized around the spindle. Knockdown of the Axin1 gene by microinjection of specific short interfering (si)RNA into the oocyte cytoplasm resulted in severely defective spindles, misaligned chromosomes, failure of first polar body (PB1) extrusion, and impaired pronuclear formation. However, supplementing the culture medium with the Wnt pathway activator LiCl improved spindle morphology and pronuclear formation. Downregulation of Axin1 gene expression also impaired the spindle pole localization of γ-tubulin/Nek9 and resulted in retention of the spindle assembly checkpoint protein BubR1 at kinetochores after 8.5 h of culture. Our results suggest that Axin-1 is critical for spindle organization and cell cycle progression during meiotic maturation in mouse oocytes. Show less
📄 PDF DOI: 10.1371/journal.pone.0157197
AXIN1
Menno J Oudhoff, Mitchell J S Braam, Spencer A Freeman +16 more · 2016 · Developmental cell · Elsevier · added 2026-04-24
Intestinal tumorigenesis is a result of mutations in signaling pathways that control cellular proliferation, differentiation, and survival. Mutations in the Wnt/β-catenin pathway are associated with t Show more
Intestinal tumorigenesis is a result of mutations in signaling pathways that control cellular proliferation, differentiation, and survival. Mutations in the Wnt/β-catenin pathway are associated with the majority of intestinal cancers, while dysregulation of the Hippo/Yes-Associated Protein (YAP) pathway is an emerging regulator of intestinal tumorigenesis. In addition, these closely related pathways play a central role during intestinal regeneration. We have previously shown that methylation of the Hippo transducer YAP by the lysine methyltransferase SETD7 controls its subcellular localization and function. We now show that SETD7 is required for Wnt-driven intestinal tumorigenesis and regeneration. Mechanistically, SETD7 is part of a complex containing YAP, AXIN1, and β-catenin, and SETD7-dependent methylation of YAP facilitates Wnt-induced nuclear accumulation of β-catenin. Collectively, these results define a methyltransferase-dependent regulatory mechanism that links the Wnt/β-catenin and Hippo/YAP pathways during intestinal regeneration and tumorigenesis. Show less
no PDF DOI: 10.1016/j.devcel.2016.03.002
AXIN1
He Huang, Xiaotong Wu, Lulu Cao +1 more · 2016 · Monoclonal antibodies in immunodiagnosis and immunotherapy · added 2026-04-24
CTRP4 (C1q/TNF-related protein 4) is a secreted cytokine homologous to adiponectin, which plays an important role in immunity and metabolism. This study was designed to generate CTRP4 monoclonal antib Show more
CTRP4 (C1q/TNF-related protein 4) is a secreted cytokine homologous to adiponectin, which plays an important role in immunity and metabolism. This study was designed to generate CTRP4 monoclonal antibodies (MAbs). Splenocytes extracted from mice immunized with prokaryotic protein were fused with myeloma cells Sp2/0 to generate hybridoma cells. Three hybridoma strains (16, 33, and 35) were chosen and their MAbs were purified. The specificity and affinity were identified by Western blot and enzyme-linked immunosorbent assay, whereas CTRP4 endogenous expression was identified by immunofluorescence staining. These MAbs could be useful tools for basic research and potential clinical application. Show less
no PDF DOI: 10.1089/mab.2016.0027
C1QTNF4
Juliet D French, Sharon E Johnatty, Yi Lu +75 more · 2016 · Oncotarget · Impact Journals · added 2026-04-24
Women with epithelial ovarian cancer (EOC) are usually treated with platinum/taxane therapy after cytoreductive surgery but there is considerable inter-individual variation in response. To identify ge Show more
Women with epithelial ovarian cancer (EOC) are usually treated with platinum/taxane therapy after cytoreductive surgery but there is considerable inter-individual variation in response. To identify germline single-nucleotide polymorphisms (SNPs) that contribute to variations in individual responses to chemotherapy, we carried out a multi-phase genome-wide association study (GWAS) in 1,244 women diagnosed with serous EOC who were treated with the same first-line chemotherapy, carboplatin and paclitaxel. We identified two SNPs (rs7874043 and rs72700653) in TTC39B (best P=7x10-5, HR=1.90, for rs7874043) associated with progression-free survival (PFS). Functional analyses show that both SNPs lie in a putative regulatory element (PRE) that physically interacts with the promoters of PSIP1, CCDC171 and an alternative promoter of TTC39B. The C allele of rs7874043 is associated with poor PFS and showed increased binding of the Sp1 transcription factor, which is critical for chromatin interactions with PSIP1. Silencing of PSIP1 significantly impaired DNA damage-induced Rad51 nuclear foci and reduced cell viability in ovarian cancer lines. PSIP1 (PC4 and SFRS1 Interacting Protein 1) is known to protect cells from stress-induced apoptosis, and high expression is associated with poor PFS in EOC patients. We therefore suggest that the minor allele of rs7874043 confers poor PFS by increasing PSIP1 expression. Show less
📄 PDF DOI: 10.18632/oncotarget.7047
CCDC171
Madhu M Ouseph, Mark E Kleinman, Qing Jun Wang · 2016 · Annals of the New York Academy of Sciences · Blackwell Publishing · added 2026-04-24
Juvenile neuronal ceroid lipofuscinosis (JNCL; also known as CLN3 disease) is a devastating neurodegenerative lysosomal storage disorder and the most common form of Batten disease. Progressive visual Show more
Juvenile neuronal ceroid lipofuscinosis (JNCL; also known as CLN3 disease) is a devastating neurodegenerative lysosomal storage disorder and the most common form of Batten disease. Progressive visual and neurological symptoms lead to mortality in patients by the third decade. Although ceroid-lipofuscinosis, neuronal 3 (CLN3) has been identified as the sole disease gene, the biochemical and cellular bases of JNCL and the functions of CLN3 are yet to be fully understood. As severe ocular pathologies manifest early in disease progression, the retina is an ideal tissue to study in the efforts to unravel disease etiology and design therapeutics. There are significant discrepancies in the ocular phenotypes between human JNCL and existing murine models, impeding investigations on the sequence of events occurring during the progression of vision impairment. This review focuses on current understanding of vision loss in JNCL and discusses future research directions toward molecular dissection of the pathogenesis of the disease and associated vision problems in order to ultimately improve the quality of patient life and cure the disease. Show less
📄 PDF DOI: 10.1111/nyas.12990
CLN3
Chi Yang, Rao Fu, Zhenhong Zhuang +1 more · 2016 · Gene · Elsevier · added 2026-04-24
Carbamyl phosphate synthetase 1 (CPS1) was down-regulated in hepatocellular carcinoma (HCC), as treated by aflatoxin B1 (AFB1), a potent hepatocarcinogenesis mycotoxin. In this study, we firstly confi Show more
Carbamyl phosphate synthetase 1 (CPS1) was down-regulated in hepatocellular carcinoma (HCC), as treated by aflatoxin B1 (AFB1), a potent hepatocarcinogenesis mycotoxin. In this study, we firstly confirmed that AFB1 down-regulated the expression of CPS1 in a dose-dependent manner. At the meantime, both siRNA knock down of CPS1 and AFB1 treatment inhibited cell proliferation, and induced cell apoptosis. To further analysis the function of CPS1, the interacting proteins of CPS1 were searched by Co-IP, and three interacting proteins including type II cytoskeletal 1 (KRT1), albumin (ALB), and ubiquitin C (UBC) were found. Both KRT1 and ALB were new interacting proteins for CPS1. Our further study showed that CPS1 was regulating interacted and colocalized with KRT1 and ALB, and the intensity correlation was changed by AFB1. KRT1, ALB and CPS1 were all reported to play an important role in differentiation and tissue specialization. These results may offer an increasing understand that CPS1 might have a function in differentiation. Show less
no PDF DOI: 10.1016/j.gene.2016.07.031
CPS1
Tong-Hong Wang, Cheng-Chia Yu, Yong-Shiang Lin +6 more · 2016 · Oncotarget · Impact Journals · added 2026-04-24
Recently, increasing numbers of long noncoding RNAs (lncRNAs), with both oncogenic and tumor-suppressive potential, have been found to be aberrantly expressed in various human cancers. However, the fu Show more
Recently, increasing numbers of long noncoding RNAs (lncRNAs), with both oncogenic and tumor-suppressive potential, have been found to be aberrantly expressed in various human cancers. However, the function of lncRNAs in hepatocellular carcinoma (HCC) progression remains largely unknown. In this study, we performed a comprehensive microarray analysis of lncRNA expression using human HCC specimens. After validation in 119 human HCC tissues, we identified a novel tumor suppressor lncRNA, CPS1 intronic transcript 1 (CPS1-IT1). To elucidate the clinical significance of CPS1-IT1 in HCC, correlations between CPS1-IT1 levels, clinical parameters, and survival outcomes were analyzed. In vitro and in vivo functional assays were also performed to dissect the potential underlying mechanisms. Expression of CPS1-IT1 was significantly decreased in 73% of HCC tissues, and patients with low CPS1-IT1 expression had poor survival outcomes. Furthermore, in vitro functional assays indicated that CPS1-IT1 significantly reduced cell proliferation, migration and invasion capacities through reduced Hsp90 binding to and activation of HIF-1α, thereby suppressing the epithelial-mesenchymal transition (EMT). An in vivo animal model also demonstrated the tumor suppressor role of CPS1- IT1 via decreased tumor growth and metastasis. In conclusion, lncRNA CPS1-IT1 acts as a tumor suppressor in HCC by reducing HIF-1α activation and suppressing EMT. The findings of this study establish a function for CPS1-IT1 in HCC progression and suggest its potential as a new prognostic biomarker and target for HCC therapy. Show less
📄 PDF DOI: 10.18632/oncotarget.9635
CPS1
Lulu Li, Ping Zhang, Zhengxi Bao +3 more · 2016 · Scientific reports · Nature · added 2026-04-24
Excess ammonia is produced during fasting when amino acids are used for glucogenesis. Together with ureagenesis, glucogenesis occurs in periportal hepatocytes mediated mainly through the peroxisome pr Show more
Excess ammonia is produced during fasting when amino acids are used for glucogenesis. Together with ureagenesis, glucogenesis occurs in periportal hepatocytes mediated mainly through the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). In vivo experiments showed that fasting strongly stimulated mice glucagon secretion, hepatic PGC-1α, sirtuin 3 (SIRT3) and sirtuin 5 (SIRT5) expression and ureagenesis enzymatic activity such as carbamoyl phosphate synthetase 1 (CPS1) and ornithine transcarbamoylase (OTC). Interestingly, (15)N-labeled urea and (13)C-labeled glucose production in wild-type mice were significantly increased compared with PGC-1α null mice by [(15)N,(13)C]alanine perfused liver. Glucagon significantly stimulated ureagenesis, expression of SIRT3, SIRT5 and the activities of CPS1 and OCT but did not stimulate PGC-1α silencing hepatocytes in mice periportal hepatocytes. Contrarily, PGC-1α overexpression significantly increased the expression of SIRT3, SIRT5 and the activities of CPS1 and OTC, but induced no significant changes in CPS1 and OTC expression. Morever, SIRT3 directly deacetylates and upregulates the activity of OTC, while SIRT5 deacetylates and stimulates the activity of CPS1. During fasting, PGC-1α facilitates ureagenesis in mouse periportal hepatocytes by deacetylating CPS1 and OTC modulated by mitochondrial deacetylase, SIRT3 and SIRT5. This mechanism may be relevant to ammonia detoxification and metabolic homeostasis in liver during fasting. Show less
📄 PDF DOI: 10.1038/srep24156
CPS1
Jaana A Hartiala, W H Wilson Tang, Zeneng Wang +8 more · 2016 · Nature communications · Nature · added 2026-04-24
Metabolites derived from dietary choline and L-carnitine, such as trimethylamine N-oxide and betaine, have recently been identified as novel risk factors for atherosclerosis in mice and humans. We sou Show more
Metabolites derived from dietary choline and L-carnitine, such as trimethylamine N-oxide and betaine, have recently been identified as novel risk factors for atherosclerosis in mice and humans. We sought to identify genetic factors associated with plasma betaine levels and determine their effect on risk of coronary artery disease (CAD). A two-stage genome-wide association study (GWAS) identified two significantly associated loci on chromosomes 2q34 and 5q14.1. The lead variant on 2q24 (rs715) localizes to carbamoyl-phosphate synthase 1 (CPS1), which encodes a mitochondrial enzyme that catalyses the first committed reaction and rate-limiting step in the urea cycle. Rs715 is also significantly associated with decreased levels of urea cycle metabolites and increased plasma glycine levels. Notably, rs715 yield a strikingly significant and protective association with decreased risk of CAD in only women. These results suggest that glycine metabolism and/or the urea cycle represent potentially novel sex-specific mechanisms for the development of atherosclerosis. Show less
📄 PDF DOI: 10.1038/ncomms10558
CPS1
Hui Liu, Hongxia Zhang, Ruina Cui +3 more · 2016 · Archives of toxicology · Springer · added 2026-04-24
Perfluorododecanoic acid (PFDoA) is a ubiquitous environmental pollutant known to cause hepatocellular hypertrophy; however, the mechanisms of hepatotoxicity remain poorly understood. In this study, m Show more
Perfluorododecanoic acid (PFDoA) is a ubiquitous environmental pollutant known to cause hepatocellular hypertrophy; however, the mechanisms of hepatotoxicity remain poorly understood. In this study, male rats were exposed to 0, 0.05, 0.2 and 0.5 mg/kg/day of PFDoA for 110 days. After two-dimensional differential gel electrophoresis and MALDI-TOF/TOF analysis, 73 differentially expressed proteins involved in lipid metabolism, inflammation, stress response and other functions were successfully identified. Among them, six significantly changed proteins (CTE1, MTE1, HADHA, ECH1, ALDH2 and CPS1) were found to be regulated by peroxisome proliferator-activated receptor alpha (PPARα). The anti-oxidant enzyme activity assays of superoxide dismutase and glutathione peroxidase and the content of thiobarbituric acid-reactive substances in the liver implied that PFDoA caused oxidative stress. The mRNA levels of PPARα in rat primary hepatocytes were knocked down by lentivirus-mediated RNAi. Furthermore, targeted protein levels of CTE1 and MTE1 were down-regulated, while those of HADHA, ALDH2 and CPS1 were up-regulated. After PFDoA exposure, however, the targeted protein levels of CTE1 and ALDH2 increased compared with those of the knockdown untreated group. The reactive oxygen species (ROS) content in rat hepatocytes assayed by flow cytometry significantly increased in the PPARα knockdown groups, consistent with the PPARα antagonist GW6471- and agonist WY14643-treated groups. These results strongly suggested that PPARα played an important role in suppressing ROS content in hepatocytes following PFDoA exposure. Show less
no PDF DOI: 10.1007/s00204-015-1559-9
CPS1
Jingrui Xing, Hiroki Kimura, Chenyao Wang +14 more · 2016 · Scientific reports · Nature · added 2026-04-24
PSD-95 associated PSD proteins play a critical role in regulating the density and activity of glutamate receptors. Numerous previous studies have shown an association between the genes that encode the Show more
PSD-95 associated PSD proteins play a critical role in regulating the density and activity of glutamate receptors. Numerous previous studies have shown an association between the genes that encode these proteins and schizophrenia (SZ) and autism spectrum disorders (ASD), which share a substantial portion of genetic risks. We sequenced the protein-encoding regions of DLG1, DLG2, DLG4, DLGAP1, DLGAP2, and SynGAP in 562 cases (370 SZ and 192 ASD patients) on the Ion PGM platform. We detected 26 rare (minor allele frequency <1%), non-synonymous mutations, and conducted silico functional analysis and pedigree analysis when possible. Three variants, G344R in DLG1, G241S in DLG4, and R604C in DLGAP2, were selected for association analysis in an independent sample set of 1315 SZ patients, 382 ASD patients, and 1793 healthy controls. Neither DLG4-G241S nor DLGAP2-R604C was detected in any samples in case or control sets, whereas one additional SZ patient was found that carried DLG1-G344R. Our results suggest that rare missense mutations in the candidate PSD genes may increase susceptibility to SZ and/or ASD. These findings may strengthen the theory that rare, non-synonymous variants confer substantial genetic risks for these disorders. Show less
📄 PDF DOI: 10.1038/srep27491
DLG2
Tao Guo, Rui-Xing Yin, Wei-Xiong Lin +3 more · 2016 · Journal of cellular and molecular medicine · Blackwell Publishing · added 2026-04-24
Little is known about the association between the single nucleotide polymorphisms (SNPs) and haplotypes of the dedicator of cytokinesis 7 (DOCK7), pro-protein convertase subtilisin/kexin type 9 (PCSK9 Show more
Little is known about the association between the single nucleotide polymorphisms (SNPs) and haplotypes of the dedicator of cytokinesis 7 (DOCK7), pro-protein convertase subtilisin/kexin type 9 (PCSK9) and polypeptide N-acetylgalactosaminyltransferase 2 (GALNT2) and serum lipid traits in the Chinese populations. This study was to determine the association between nine SNPs in the three genes and their haplotypes and hypercholesterolaemia (HCH)/hypertriglyceridaemia (HTG), and to identify the possible gene-gene interactions among these SNPs. Genotyping was performed in 733 HCH and 540 HTG participants. The haplotype of C-C-G-C-T-G-C-C-G [in the order of DOCK7 rs1168013 (G>C), rs10889332 (C>T); PCSK9 rs615563 (G>A), rs7552841 (C>T), rs11206517 (T>G); and GALNT2 rs1997947 (G>A), rs2760537 (C>T), rs4846913 (C>A) and rs11122316 (G>A) SNPs] was associated with increased risk of HCH and HTG. The haplotypes of C-C-G-C-T-G-C-C-A and G-C-G-T-T-G-T-C-G were associated with a reduced risk of HCH and HTG. The haplotypes of G-C-G-C-T-G-C-C-A and G-C-G-C-T-G-T-C-G were associated with increased risk of HCH. The haplotypes of C-T-G-C-T-G-C-C-G, G-C-A-C-T-G-C-C-G and G-C-G-C-T-G-C-C-A were associated with an increased risk of HTG. The haplotypes of G-C-G-C-T-G-T-C-A and G-C-G-T-T-G-T-C-G were associated with a reduced risk of HTG. In addition, possible inter-locus interactions among the DOCK7, PCSK9 and GALNT2 SNPs were also noted. However, further functional studies of these genes are still required to clarify which SNPs are functional and how these genes actually affect the serum lipid levels. Show less
📄 PDF DOI: 10.1111/jcmm.12713
DOCK7
Oona Delpuech, Claire Rooney, Lorraine Mooney +12 more · 2016 · Molecular cancer therapeutics · added 2026-04-24
The challenge of developing effective pharmacodynamic biomarkers for preclinical and clinical testing of FGFR signaling inhibition is significant. Assays that rely on the measurement of phospho-protei Show more
The challenge of developing effective pharmacodynamic biomarkers for preclinical and clinical testing of FGFR signaling inhibition is significant. Assays that rely on the measurement of phospho-protein epitopes can be limited by the availability of effective antibody detection reagents. Transcript profiling enables accurate quantification of many biomarkers and provides a broader representation of pathway modulation. To identify dynamic transcript biomarkers of FGFR signaling inhibition by AZD4547, a potent inhibitor of FGF receptors 1, 2, and 3, a gene expression profiling study was performed in FGFR2-amplified, drug-sensitive tumor cell lines. Consistent with known signaling pathways activated by FGFR, we identified transcript biomarkers downstream of the RAS-MAPK and PI3K/AKT pathways. Using different tumor cell lines in vitro and xenografts in vivo, we confirmed that some of these transcript biomarkers (DUSP6, ETV5, YPEL2) were modulated downstream of oncogenic FGFR1, 2, 3, whereas others showed selective modulation only by FGFR2 signaling (EGR1). These transcripts showed consistent time-dependent modulation, corresponding to the plasma exposure of AZD4547 and inhibition of phosphorylation of the downstream signaling molecules FRS2 or ERK. Combination of FGFR and AKT inhibition in an FGFR2-mutated endometrial cancer xenograft model enhanced modulation of transcript biomarkers from the PI3K/AKT pathway and tumor growth inhibition. These biomarkers were detected on the clinically validated nanoString platform. Taken together, these data identified novel dynamic transcript biomarkers of FGFR inhibition that were validated in a number of in vivo models, and which are more robustly modulated by FGFR inhibition than some conventional downstream signaling protein biomarkers. Mol Cancer Ther; 15(11); 2802-13. ©2016 AACR. Show less
no PDF DOI: 10.1158/1535-7163.MCT-16-0297
DUSP6
Yun Zhou, Guang Y Li, Jun P Ren +9 more · 2016 · Journal of leukocyte biology · added 2026-04-24
T cell dysfunction has a crucial role in establishing and maintaining viral persistence. We have previously shown a decline in miR-181a, which regulates CD4
no PDF DOI: 10.1189/jlb.5A0316-119RR
DUSP6
Tian-Lu Wang, Ying-Qiu Song, Yang-Wu Ren +6 more · 2016 · Clinical laboratory · added 2026-04-24
Dual-specificity phosphatase 6 (DUSP6) inactivates different target kinases to regulate cell proliferation and differentiation. Altered DUSP6 expressions or gene polymorphisms are associated with huma Show more
Dual-specificity phosphatase 6 (DUSP6) inactivates different target kinases to regulate cell proliferation and differentiation. Altered DUSP6 expressions or gene polymorphisms are associated with human cancer development including non-small cell lung cancer (NSCLC). DNA topoisomerase II alpha (TOP2A) regulates chromosome condensation and chromatid separation, and altered TOP2A expressions are associated with drug resistance development. This study assessed DUSP6 and TOP2A single nucleotide polymorphisms (SNPs) associated with NSCLC patient survival. This study included 152 surgically resected NSCLC patients and 277 chemoradiotherapy treated inoperable cases. DNA samples from each patient were genotyped for DUSP6 and TOP2A SNPs. Kaplan-Meier survival analysis, log-rank test, and Cox proportional hazard model were used to evaluate the association between these variants and NSCLC overall survival. DUSP6 rs2279574 A/A genotype was associated with significantly poor inoperable NSCLC patient overall survival (A/A vs. C/C, adjusted HR = 1.549, 95% CI = 1.019-2.355). Stratification analysis against clinical stage, histology, weight loss, and ECOG performance status revealed that the DUSP6 rs2279574 A/A variant homozygous genotype is associated with a decrease in survival of stage IV NSCLC patients compared to those with the C/C genotype (log-rank, p = 0.003). No association was found among histology, weight loss, and ECOG performance status. Moreover, there was no association of TOP2A SNPs between clinicopathological and survival data. Data obtained from the current study demonstrated that functional DUSP6 rs2279574 polymorphism was able to predict inoperable NSCLC patient survival after chemoradiotherapy. Show less
no PDF DOI: 10.7754/clin.lab.2015.150432
DUSP6
Yun Ma, Shuai Tian, Shuya He +5 more · 2016 · Gene · Elsevier · added 2026-04-24
The biological effects of microRNAs (miRNAs) in the Fragile X Syndrome (FXS) have been widely studied. Dysregulation of miRNAs plays a critical role in the progression of nervous system diseases and i Show more
The biological effects of microRNAs (miRNAs) in the Fragile X Syndrome (FXS) have been widely studied. Dysregulation of miRNAs plays a critical role in the progression of nervous system diseases and in cell proliferation and differentiation. Our previous study validated that miR-19b-3p was associated with FXR1 (Fragile X related gene 1), one of homologous genes of FMR1 (Fragile X mental retardation 1). The purpose of this study was to investigate the relationship of FXR1 and miR-19b-3p, and the crucial role of miR-19b-3p in FXS and to validate whether miR-19b-3p could regulate the growth of SH-SY5Y cells. We determined that miR-19b-3p could regulate the expression of not only USP32, RAB18 and Dusp6 but also FXR1, and FXR1 could in turn regulate the expression of miR-19b-3p. What's more, the overexpression of miR-19b-3p significantly inhibited the proliferation, contributed the apoptosis and slowed down the cycle of SH-SY5Y cells. Taken together, our results indicate that miR-19b-3p plays a significant role in the molecular pathology of FXS by interacting with FXR1 and influencing the growth of SH-SY5Y cells. Show less
no PDF DOI: 10.1016/j.gene.2016.04.037
DUSP6
JaeHyung Koo, Sen Wang, NaNa Kang +2 more · 2016 · BMB reports · added 2026-04-24
Ras oncoproteins are small molecular weight GTPases known for their involvement in oncogenesis, which operate in a complex signaling network with multiple effectors. Approximately 25% of human tumors Show more
Ras oncoproteins are small molecular weight GTPases known for their involvement in oncogenesis, which operate in a complex signaling network with multiple effectors. Approximately 25% of human tumors possess mutations in a member of this family. The Raf1/MEK/Erk1/2 pathway is one of the most intensively studied signaling mechanisms. Different levels of regulation account for the inactivation of MAP kinases by MAPK phosphatases in a cell type- and stimuli-dependent manner. In the present study, using three inducible Ras-expressing NIH/3T3 cell lines, we demonstrated that MKP3 upregulation requires the activation of the Erk1/2 pathway, which correlates with the shutdown of this pathway. We also demonstrated, by applying pharmacological inhibitors and effector mutants of Ras, that induction of MKP3 at the protein level is positively regulated by the oncogenic Ras/Raf/MEK/Erk1/2 signaling pathway. [BMB Reports 2016; 49(7): 370-375]. Show less
📄 PDF DOI: 10.5483/bmbrep.2016.49.7.256
DUSP6
Jie Zhu, Qinghang Wang, Yumei Nie +3 more · 2016 · Medical science monitor : international medical journal of experimental and clinical research · added 2026-04-24
BACKGROUND Apoptosis plays an important role in the physiology of platelet function. We aimed to detect the effect of the platelet integrin αIIbβ3 inhibitor, tirofiban, on apoptotic events, including Show more
BACKGROUND Apoptosis plays an important role in the physiology of platelet function. We aimed to detect the effect of the platelet integrin αIIbβ3 inhibitor, tirofiban, on apoptotic events, including mitochondrial inner-membrane potential (ΔΨm), phosphatidylserine (PS) exposure on platelet surface, and the generation of reactive oxygen species (ROS), when washed platelets were stimulated with thrombin. MATERIAL AND METHODS The study included washed platelets from healthy humans, divided into 4 groups: vehicle, and tirofiban (0.05 μg/ml, 0.25 μg/ml, and 0.5 μg/ml). Platelets were pretreated with vehicle or tirofiban and incubated at 37°C with agitation for 6 h and 24 h. Before thrombin addition, the vehicle group divided into 2 equal groups. Except one vehicle group, the other 4 groups were all stimulated with thrombin (1 U/ml) for 30 min at 37°C. Using flow cytometry, we studied the DYm and PS exposure on platelet surfaces, and the generation of ROS in platelets. RESULTS We observed that at the time of 6 h and 24 h, thrombin-stimulated vehicle platelets induced significant depo-larization of ΔΨm, higher PS exposure, and increased ROS production compared with the vehicle group (P<0.01). However, the tirofiban group had significantly more recovery of DYm, PS exposure, and ROS production compared with the thrombin group (P<0.01). CONCLUSIONS The platelet integrin αIIbβ3 inhibitor, tirofiban, inhibits the depolarization of DYm, PS exposure on platelet surface, and ROS production when stimulated with thrombin. These results suggest that αIIbβ3 inhibitor inhibits the initiation of apoptosis in platelets, showing a potential clinical application of tirofiban as an apoptosis inhibitor. Show less
📄 PDF DOI: 10.12659/msm.900820
DYM
Tze-Kiong Er, Yu-Fa Su, Chun-Chieh Wu +9 more · 2016 · Journal of molecular medicine (Berlin, Germany) · Springer · added 2026-04-24
Recent molecular and pathological studies suggest that endometriosis may serve as a precursor of ovarian cancer (endometriosis-associated ovarian cancer, EAOC), especially of the endometrioid and clea Show more
Recent molecular and pathological studies suggest that endometriosis may serve as a precursor of ovarian cancer (endometriosis-associated ovarian cancer, EAOC), especially of the endometrioid and clear cell subtypes. Accordingly, this study had two cardinal aims: first, to obtain mutation profiles of EAOC from Taiwanese patients; and second, to determine whether somatic mutations present in EAOC can be detected in preneoplastic lesions. Formalin-fixed paraffin-embedded (FFPE) tissues were obtained from ten endometriosis patients with malignant transformation. Macrodissection was performed to separate four different types of cells from FFPE sections in six patients. The four types of samples included normal endometrium, ectopic endometriotic lesion, atypical endometriosis, and carcinoma. Ultra-deep (>1000×) targeted sequencing was performed on 409 cancer-related genes to identify pathogenic mutations associated with EAOC. The most frequently mutated genes were PIK3CA (6/10) and ARID1A (5/10). Other recurrently mutated genes included ETS1, MLH1, PRKDC (3/10 each), and AMER1, ARID2, BCL11A, CREBBP, ERBB2, EXT1, FANCD2, MSH6, NF1, NOTCH1, NUMA1, PDE4DIP, PPP2R1A, RNF213, and SYNE1 (2/10 each). Importantly, in five of the six patients, identical somatic mutations were detected in atypical endometriosis and tumor lesions. In two patients, genetic alterations were also detected in ectopic endometriotic lesions, indicating the presence of genetic alterations in preneoplastic lesion. Genetic analysis in preneoplastic lesions may help to identify high-risk patients at early stage of malignant transformation and also shed new light on fundamental aspects of the molecular pathogenesis of EAOC. Molecular characterization of endometriosis-associated ovarian cancer genes by targeted NGS. Candidate genes predictive of malignant transformation were identified. Chromatin remodeling, PI3K-AKT-mTOR, Notch signaling, and Wnt/β-catenin pathway may promote cell malignant transformation. Show less
no PDF DOI: 10.1007/s00109-016-1395-2
EXT1
Perla C Reyes Fernandez, Rebecca A Replogle, Libo Wang +2 more · 2016 · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · Wiley · added 2026-04-24
Low dietary calcium (Ca) intake during growth limits peak bone mass but physiological adaptation can prevent this adverse effect. To assess the genetic control on the physiologic response to dietary C Show more
Low dietary calcium (Ca) intake during growth limits peak bone mass but physiological adaptation can prevent this adverse effect. To assess the genetic control on the physiologic response to dietary Ca restriction (RCR), we conducted a study in 51 BXD lines fed either 0.5% (basal) or 0.25% (low) Ca diets from ages 4 to 12 weeks (n = 8/line/diet). Ca absorption (CaAbs), femur bone mineral density (BMD), and bone mineral content (BMC) were examined. ANCOVA with body size as covariate was used to detect significant line and diet main effects, and line-by-diet interactions. Body size-corrected residuals were used for linkage mapping and to estimate heritability (h(2) ). Loci controlling the phenotypes were identified using composite interval mapping on each diet and for the RCR. h(2) of basal phenotypes (0.37-0.43) and their RCR (0.32-0.38) was moderate. For each phenotype, we identified multiple quantitative trait loci (QTL) on each diet and for the RCR. Several loci affected multiple traits: Chr 1 (88.3-90.6 cM, CaAbs, BMC), Chr 4 (45.8-49.2 cM, CaAbs, BMD, BMC), Chr 8 (28.6-31.6 cM, CaAbs, BMD, RCR), and Chr 15 (13.6-24 cM, BMD, BMC; 32.3-36 cM, CaAbs RCR, BMD). This suggests that gene clusters may regulate interdependent bone-related phenotypes. Using in silico expression QTL (eQTL) mapping and bioinformatic tools, we identified novel candidates for the regulation of bone under Ca stress (Ext1, Deptor), and for the first time, we report genes modulating Ca absorption (Inadl, Sc4mol, Sh3rf1, and Dennd3), and both Ca and bone metabolism (Tceanc2, Tll1, and Aadat). Our data reveal gene-by-diet interactions and the existence of novel relationships between bone and Ca metabolism during growth. © 2015 American Society for Bone and Mineral Research. Show less
📄 PDF DOI: 10.1002/jbmr.2760
EXT1
Hang Su, Dan Zhou, Yuan-Xiang Pan +2 more · 2016 · Journal of lipid research · added 2026-04-24
In mammals, because they share a single synthetic pathway, n-6/n-3 ratios of dietary PUFAs impact tissue arachidonic acid (ARA) and DHA content. Likewise, SNPs in the human fatty acid desaturase (FADS Show more
In mammals, because they share a single synthetic pathway, n-6/n-3 ratios of dietary PUFAs impact tissue arachidonic acid (ARA) and DHA content. Likewise, SNPs in the human fatty acid desaturase (FADS) gene cluster impact tissue ARA and DHA. Here we tested the feasibility of using heterozygous Fads2-null-mice (HET) as an animal model of human FADS polymorphisms. WT and HET mice were fed diets with linoleate/α-linolenate ratios of 1:1, 7:1, and 44:1 at 7% of diet. In WT liver, ARA and DHA in phospholipids varied >2× among dietary groups, reflecting precursor ratios. Unexpectedly, ARA content was only <10% lower in HET than in WT livers, when fed the 44:1 diet, likely due to increased Fads1 mRNA in response to reduced Fads2 mRNA in HET. Consistent with the RNA data, C20:3n-6, which is elevated in minor FADS haplotypes in humans, was lower in HET than WT. Diet and genotype had little effect on brain PUFAs even though brain Fads2 mRNA was low in HET. No differences in cytokine mRNA were found among groups under unstimulated conditions. In conclusion, differential PUFA profiles between HET mice and human FADS SNPs suggest low expression of both FADS1 and 2 genes in human minor haplotypes. Show less
no PDF DOI: 10.1194/jlr.M064956
FADS1
Hong Li, Zheng Ma, Lijuan Jia +9 more · 2016 · Scientific reports · Nature · added 2026-04-24
Laying performance is an important economic trait in hens, and this physiological process is largely influenced by the liver function. The livers of hens at 20- and 30-week-old stages were investigate Show more
Laying performance is an important economic trait in hens, and this physiological process is largely influenced by the liver function. The livers of hens at 20- and 30-week-old stages were investigated using the next generation sequencing to identify the differences of microRNA expression profiles. Compared with the 20-week-old hens, 67 down- and 13 up-regulated microRNAs were verified to be significant differentially expressed (false discovery rate, FDR ≤ 0.05) (SDE) in the 30-week-old. We also identified 13 down- and 6 up-regulated novel differentially expressed (DE) microRNAs. miR-22-3p and miR-146b-5p, which exhibit critical roles in mammalian lipid metabolism, showed the most abundant expression and the highest fold-change, respectively. A total of 648 potential target genes of the SDE microRNAs were identified through an integrated analysis of microRNAs and the DE genes obtained in previous RNA-sequencing, including FADS1, FADS2, ELOVL6 and ACSL5, which are critical lipid metabolism-related regulators. Bioinformatic analyses revealed that target genes were mainly enriched in lipid-related metabolism processes. This work provides the first study of the expression patterns of hepatic microRNAs between 20- and 30-week old hens. The findings may serve as a fundamental resource for understanding the detailed functions of microRNAs in the molecular regulatory systems of lipid metabolism. Show less
📄 PDF DOI: 10.1038/srep31766
FADS1
Dong Wang, Yan Lin, Bei Gao +5 more · 2016 · Journal of Cancer · added 2026-04-24
Fatty acid desaturase 1 is a member of the fatty acid desaturase, which is related to a number of diseases. However, its role in cancers remains unclear. This study was to explore the clinical importa Show more
Fatty acid desaturase 1 is a member of the fatty acid desaturase, which is related to a number of diseases. However, its role in cancers remains unclear. This study was to explore the clinical importance of FADS1 expression in non-small-cell lung cancer (NSCLC). Immunochemistry was used to evaluate FADS1 expressions in 216 paraffin-embedded specimens. The expression of FADS1 was divided into high and low groups. The clinical and prognostic significance of FADS1 expression was analyzed statistically by Kaplan-Meier estimate and Cox regression model. FADS1 overexpressed in normal bronchial mucosa compared with non-small-cell lung cancer. Reduced FADS1 expression was associated with tumor size (P=0.023) and histological grade (P<0.0001). Patients with lower expression of FADS1 had shorter overall survival and disease free survival (P=0.001 and P=0.002). Multivariate analysis showed FADS1 expression was an independent prognostic factor in NSCLC (P=0.011). Reduced expression of FADS1 suggests pessimistic prognosis for NSCLC patients. Further studies are warranted. Show less
📄 PDF DOI: 10.7150/jca.15403
FADS1